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Three aspects of steroidogenic control in bovine adrenocortical cells have been 
considered:
(i) Cholesterol supply.
(ii) Calcium metabolism.
(iii) Activity of steroidogenic enzymes.
The effects of dantrolene, high density lipoprotein cholesterol isoquinoline 
carboxamides and benzodiazepines, agents reported to act specifically on each control 
element, have been assessed.
(a) Dantrolene
Dantrolene is a drug which reputedly blocks specifically hormone-stimulated 
release of Ca2+ from intracellular stores.
Dantrolene abolished the aldosterone response to angiotensin-II (A-II). However, 
aldosterone synthesis, from added hydroxycholesterol, was more sensitive to 
inhibition by dantrolene (IC^ 0.02mmol/l) than A-II-stimulated synthesis although 
high concentrations of the drug (0.2mmol/l) did not totally abolish aldosterone 
synthesis in hydroxycholesterol-treated cells.
Aldosterone synthesis in cells incubated with hydroxycholesterol, pregnenolone, 
progesterone, 11-deoxycorticosterone (DOC), corticosterone and 18- 
hydroxycorticosterone was significantly inhibited (p<0.05) by 89%, 69%, 59%, 31%, 
62% and 28% respectively in the presence of 0.2mmol/l dantrolene.
In zona fasiculata/reticularis cells, dantrolene (0.2mmol/l) significantly reduced 
cortisol production in cells treated with hydroxycholesterol (p<0.001) but not in those 
treated with pregnenolone or progesterone.
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In isolated mitochondria, dantrolene significantly reduced pregnenolone production 
from added hydroxycholesterol (92%; p<0.001), aldosterone production from added 
corticosterone (31%; p<0.001) and cortisol production from added 11-deoxycortisol 
(27%; p<0.01).
Dantrolene appears not only to inhibit steroidogenesis by preventing A-II- 
stimulated release of intracellular calcium, but also to directly inhibit steroidogenic 
enzymes, in particular cholesterol side-chain cleavage activity.
(b) High Density Lipoproteins
Previous studies have established that HDL is readily utilised as a substrate for 
steroidogenesis. However, studies in platelets suggest that HDL subfractions may 
differentially interfere with signal-response coupling with variable consequences on 
platelet aggregation.
In freshly isolated cells HDL-2 and HDL-3 increased basal aldosterone (1.5-3.5 
fold) and cortisol synthesis (1.3-6.5 fold) in a dose-dependent manner. Both 
subfractions potentiated A-II stimulated aldosterone synthesis at low concentrations 
of peptide (1010 mol/1: 1.5 fold) but had little effect at maximal concentrations of 
A-II (10'7mol/l). Cortisol synthesis at both low (10‘10mol/L: 1.8-2.3 fold) and high (10' 
7mol/l: 2.2-2.6 fold) concentrations of A-II was further increased by HDL.
In cultured cells treated with HDL-cholesterol, basal aldosterone (3 and 3.1 fold) 
and cortisol synthesis (12 and 15 fold) was increased more than in cultured cells 
stimulated with A-II (lO^mol/l). The response to A-II in the presence of HDL- 
cholesterol was a 10-14 fold increase in aldosterone synthesis and a 6.5-1.6 fold 
increase in cortisol synthesis. This compared with a 30 fold increase in aldosterone 
and a 42 fold increase in cortisol in cells not treated with HDL.
Neither HDL-2 nor HDL-3 (0.4mmol/l cholesterol) had any effect on acute ^Ca
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uptake in isolated zona glomerulosa cells. This was measured thirty seconds after 
addition of label. Under steady-state conditions (after thirty minutes), both 
subfractions significantly decreased 45Ca uptake when compared with control (15%; 
p<0.01). No significant effects were observed on concentrations of basal and A-II- 
stimulated intracellular free calcium in zona glomerulosa cells pre-incubated with 
HDL-2 or HDL-3 for 15 mins.
In conclusion, HDL-2 and HDL-3 are similarly effective in providing substrate for 
aldosterone and cortisol synthesis. Neither subfraction has any acute effect on cell 
calcium. In the longer term, HDL-cholesterol may lower steady-state calcium content 
in adrenal cells as it does in platelets. The significance of this in signal-response 
coupling is not known.
(c) Benzodiazepines
Previous studies have suggested that benzodiazepines directly inhibit microsomal 
steroid hydroxylating enzymes at high concentrations. However, high affinity 
peripheral receptors for benzodiazepines have been identified in mitochondria of 
steroidogenic tissues (MBR) which have been linked to effects on calcium 
metabolism and/or cholesterol supply to side-chain cleavage enzyme. The effects of 
peripheral ligands on steroidogenesis were investigated using the benzodiazepines 
midazolam, diazepam and R05-4864 (4-chlorodiazepam).
(i) Midazolam: In addition to its basic benzodiazepine structure, midazolam contains 
an imidazole moiety which has been demonstrated previously to inhibit 
steroidogenesis. The affinity of the drug for the MBR is unknown.
Midazolam inhibited basal and ACTH-stimulated cortisol synthesis (IQo 22pmol/l) 
in zona fasiculata/reticularis cells. In the same experimental incubations, the drug 
(0.85-13.6pmol/l) caused an accumulation of 17-hydroxyprogesterone which
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decreased at higher concentrations (>13.6pmol/l). Midazolam inhibited conversion 
of 116-hydroxyprogesterone to aldosterone in zona glomerulosa cells (IQ q 10pmol/l) 
and 21-deoxy cortisol to cortisol in zona fasiculata/reticularis cells (IC^ 21pmol/l).
Midazolam and diazepam inhibited K+-stimulated aldosterone synthesis (IC^ 
1.2pmol/l for diazepam and 0.8pmol/l for midazolam) at lower concentrations of 
drug than that required to inhibit conversion of 116-hydroxyprogesterone to 
aldosterone, 21-deoxycortisol to cortisol or ACTH-stimulated cortisol synthesis (IC^ 
10, 21 and 22pmol/l respectively).
Midazolam reduced overall K+-stimulated 45Ca uptake in zona glomerulosa cells 
by 43% and, in addition, the drug decreased basal 45Ca uptake in the same cells at 
all concentrations between 0.85 and 55pmol/l. Zona fasiculata/reticularis cells 
appeared less sensitive to the drug, midazolam only causing significant inhibition of 
45Ca uptake at drug concentrations >13.6pmol/l.
(ii) Diazepam: Diazepam has affinity for both MBR and for well-characterised 
benzodiazepine receptors in the central nervous system. It is through the central 
receptors that the drug has its therapeutic effect as a tranquilliser and sedative.
Diazepam (10'9-10'5mol/l) increased basal aldosterone synthesis (2.3 fold) in 
cultured zona glomerulosa cells. This effect could be induced by pre-exposure to the 
drug.
A-II-stimulated aldosterone synthesis was only potentiated by diazepam when sub- 
maximal concentrations of peptide were used and when the drug was present at 
concentrations < 0.1mmol/l. At higher concentrations, diazepam inhibited stimulated 
synthesis at every A-II concentration. In cultured cells incubated with HDL- 
cholesterol and DOC, diazepam (10'9-10'5mol/l) maximally increased aldosterone 
synthesis 1.8 and 1.6 fold respectively.
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(iii) R05-4864: R05-4864 binds with high affinity to MBR but not to central 
receptors.
R05-4864 (10'9-l(L*mol/l) potentiated aldosterone synthesis (maximal 1.9 fold 
increase) in cultured zona glomerulosa cells incubated with HDL-cholesterol. In 
addition, the drug (10'9-10'7mol/l) also increased aldosterone synthesis (maximal 1.8 
fold increase) in cells incubated with added DOC.
In conclusion, depending upon the identity of drug, its concentration and the mode 
of stimulation benzodiazepines can:
(i) Increase steroidogenesis, probably by stimulating substrate delivery to the inner 
mitochondrial membrane.
(ii) Decrease steroidogenesis by inhibiting K+-stimulated uptake of extracellular 
calcium or by inhibiting steroidogenic enzymes, in particular microsomal 
hydroxylases.
(d) Isoquinoline Carboxamides (PK11195)
PK11195, like the benzodiazepine R05-4864, binds with high affinity to MBR but 
not to central receptors and has been reported as a peripheral receptor antagonist.
PK11195 (10‘9-10*7mol/l) increased aldosterone synthesis in the presence of HDL- 
cholesterol (maximal 5.3 fold stimulation) but had no effect on DOC-stimulated 
aldosterone synthesis.
The drug stimulates rather than antagonises aldosterone synthesis at the MBR, 
probably by increasing cholesterol delivery to the inner mitochondrial membrane 
although an effect on calcium metabolism at the plasma membrane cannot be 
excluded.
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CHAPTER 1.
LITERATURE REVIEW.
1.1 Mineralocorticoids and Glucocorticoids.
The adrenal cortex produces three types of steroid, two of which, 
mineralocorticoids and glucocorticoids, are important in cardiovascular regulation and 
renal homeostasis. In man and higher mammals cortisol is the major glucocorticoid 
(corticosterone in the rat) and aldosterone the major mineralocorticoid. The term 
mineralocortocoid has been applied to steroids that have distinct effects on ion 
transport by epithelial cells, resulting in sodium conservation and loss of potassium. 
Glucocorticoids are primarily involved in the regulation of carbohydrate metabolism 
but also have important effects on electrolyte metabolism.
1.2 Aldosterone
All endogenous mineralocorticoids and glucocorticoids are derived from cholesterol 
and therefore display marked structural similarities, with each containing a common 
21 carbon backbone with a cyclopentanoperhydrophenanthrene nucleus. The angular 
C-18, which is a methyl group in other steroids, is oxidised to an aldehyde group 
in aldosterone. The proximity of this group to the 116-hydroxyl group means that 
aldosterone exists in solution as a mixture of aldehyde and hemiacetal with 
equilibrium favouring the latter (1) (Fig 1.1).
13 The Adrenal Cortex.
In mammals, the adrenals are paired glands lying anterior to the kidneys. 
Histologically, the gland can be divided into two parts; a central medulla which
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secretes catecholamines and an outer cortex which secretes steroid hormones. The 
cortex is further subdivided into three zones (2) (Fig. 1.2), each of which synthesises 
a different pattern of hormones. The innermost zones are the zona fasiculata and 
zona reticularis which synthesise the major glucocorticoids cortisol and corticosterone 
plus adrenal androgens. Aldosterone is synthesised exclusively by the zona 
glomerulosa, the outermost region of the cortex. This introduction will focus mainly 
on the control of aldosterone secretion.
1.4 Biosynthesis of Aldosterone.
1.4.1 The Biosynthetic Pathway.
Fig. 1.3 displays the pathway for the formation of aldosterone from the precursor 
cholesterol (3). It involves three groups of hydroxylation reactions:
a) Cholesterol side chain cleavage.
b) C21 Hydroxylation.
c) C-11B-18 Hydroxylation.
Cholesterol side chain cleavage and C-11B-18 hydroxylation reactions take place 
in the mitochondria (4) whereas C^ hydroxylation is a microsomal reaction (5). The 
sequence of hydroxylations means that cholesterol and steroid intermediates shuttle 
between the cytoplasm, mitrochondria and microsomal compartments of the cell.
The first step, cholesterol side-chain cleavage, is an important rate-limiting step in 
aldosterone biosynthesis and is located on the matrix side of the inner mitochondrial 
membrane (6). The conversion of cholesterol to pregnenolone is a complex process 
which requires NADPH, H+ and 02 (7), for each of three consecutive mono­
oxygenase reactions that result in the oxidative cleavage of a C-C bond in the side 
chain of cholesterol (8). Pregnenolone leaves the mitochondria and is then
26
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Fig.1.3
The aldosterone biosynthetic pathway. 
Redrawn from (3), Chattoraj, 1976.
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converted to progesterone in two steps involving the oxidation of the hydroxy group 
at position 3 followed by the isomerisation of A5 to a A4 double bond. 
Deoxycorticosterone (DOC) is synthesised from progesterone by hydroxylation at C- 
21, a reaction catalysed by the microsomal enzyme, P45021. DOC leaves the 
microsomal compartment and is converted to aldosterone in the mitochondrion by 
a series of hydroxylations reactions at C -ll and C-18 to form corticosterone (B) and 
180H corticosterone (180HB) respectively. After a second hydroxylation at C-18 and 
a spontaneous loss of water, the aldehyde, aldosterone, is produced. (9).
1.4.2 Steroid Hydroxylase Enzymes.
All steroid hydroxylation reactions are catalysed by cytochrome P-450-containing 
mixed function oxidases. These enzymes are a family of heme-containing mono­
oxygenases found in a number of tissues but perhaps most studied in the liver where 
they are involved in the detoxification of drugs and other substances (10). In 
adrenocortical cells, these enzymes are found in the inner mitochondrial membrane 
and in the microsomal compartment. Cytochrome P-450 itself is the terminal 
component of an electron transport chain whose role is hydroxylation, primarily of 
lipophilic substances, rather than oxidative phosphorylation (Fig. 1.4). Reducing power 
is supplied in the form of NADPH + H+ which transfers its high potential electrons 
to a flavoprotein in this chain. The electrons are then conveyed to the non-heme 
iron protein adrenodoxin. Microsomal hydroxylases do not contain adrenodoxin but 
instead a similar role for cytochrome b5 has been suggested in electron transport to 
P45021 (11). Adrenodoxin then transfers an electron to the oxidised form of 
cytochrome P-450. Reduced P-450 then activates molecular oxygen (OJ, one atom 
of which is inserted into the substrate and the other reduced to water (Fig. 1.4).
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STEROI D + NADPH + H* + 0 2 — » S T E R O I D - O H  + NADP* + H20
Substrate (SH)
d)
P-450 (Fe,H) 
(low spin)
P-450 (Fe"‘).SH 
(high spin)
S-OH
(6)
[P-450(Fe,'/ ).SH].
e-
P-450(Fe").SH
P-450(Fe,,,).SH
o-
O.*
e
(3)
Probable ev en ts  in P 4 5 0  catalyzed steroid hydroxylation. C1) Interaction 
of steroid with P 4 5 0 ,  to  give the ferric complex. (2) One electron reduction. (3) 
Formation of P 450-su bstrate-oxygen  complex. C4) One electron reduction. C53 Addition 
of 2 H + and elimination of water, leaving proposed activated atomic oxygen spec ies .  
[ ] = hypothetical intermediate. (6) Spatial juxtaposition of active oxygen and 
substrate-^hydroxysteroid  and ferric P 4 5 0  in concerted  action
Fie.1.4
Action of cytochrome P-450 steroid hydroxylases. 
From (27), Vinson et al, 1992.
Hence these enzymes are also referred to as monoxygenases.
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1.4.3 Zone-Specific Synthesis of Aldosterone.
Aldosterone is synthesised only in the zona glomerulosa and evidence originally 
suggested the existence of a specific enzyme, corticosterone methyl oxidase 
catalysing the final two steps of aldosterone synthesis (12). In a "two enzyme" 
model (13) this would catalyse only the conversion of corticosterone to aldosterone 
and be found exclusively in the zona glomerulosa. The preceeding step, conversion 
of DOC to B would be catalysed by P45011B found in all zones of the adrenal 
cortex. This appears to be the case in the rat and in man where two forms of 
P45O110 (henceforth designated P45011B and P450a]do) with molecular weights 51Kd and 
49Kd have been identified (14,15). P450aldo differs from the major form of the 
enzyme (P45011B) in several important ways. Firstly, it is localised strictly to the two 
or three outermost cell layers in the zona glomerulosa (16) and secondly its 
expression is dependent upon dietary sodium and potassium intake: the enzyme can 
be induced in rats by sodium restriction (13,17) or by potassium repletion following 
a potassium deficient diet (13). Finally, and most importantly, it has the ability to 
synthesise aldosterone. However, in other species, most notably in the bovine adrenal 
gland, there appears to be one multi-functional enzyme P-45011B throughout the 
cortex which is capable of catalysing 11B hydroxylation of DOC and deoxycortisol 
to corticosterone and | cortisol, respectively and of the conversion of corticosterone 
to aldosterone (18,19). It follows that if aldosterone is synthesised exclusively in the 
zona glomerulosa, then this enzyme complex must be under zone specific negative 
control in the ZF/R. A number of hypotheses have been put forward to explain this 
regulation.
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(i) Substrate inhibition: Homsby (20) proposed that accumulated ZF/R steroid 
products could act either as pseudosubstrates for 11B hydroxylase, a process resulting 
in superoxide production and enzyme inactivation or as real substrates (the most 
likely candidates being cortisol (21) or androstendione) for 18 hydroxylation.
(ii) Calmodulin-mediated inhibition: Calcium-activated calmodulin (see later) 
selectively inhibits the aldosterone-synthesising activity of purified bovine 11B 
hydroxylase (22) and a calmodulin-like protein factor may be present in ZF/R cells 
which mediates this effect.
(iii) Membrane phospholipids: Enzyme configuration and catalytic activity can be 
determined by membrane phospholipid composition (23). Subtle differences in the 
phospholipid content of ZG and ZF/R mitochondria may account for differences in 
steroid output.
(iv) Availability of reducing power: ZG mitochondria contain higher concentrations 
of the enzyme semidehydroascorbate reductase than those of the ZF/R (24). 
Yanagabashi et al (24) have suggested that this enzyme provides increased reducing 
power to drive the additional hydroxylation reactions involved in aldosterone 
biosynthesis.
(v) Oxygen sensitivity: It has been demonstrated in bovine cells that aldosterone 
synthesis is particularly sensitive to p02 whereas corticosterone synthesis from DOC 
is not (25). Given the centripetal flow of blood in the cortex this means that the ZG 
on the outside is exposed to higher concentrations of 0 2 which will allow 18 
hydroxylation whereas the inner zones with lower concentrations of O* can only 
carry out 11B hydroxylations (26).
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1.5 Regulation of Aldosterone Secretion (an overview).
Aldosterone synthesis, in vivo, is under both positive and negative control by a 
number of factors (Fig. 1.5). Those exerting a positive influence include angiotensin- 
II (A-II) and adrenocorticotropin hormone (ACTH) while atrial natriuretic factor 
(ANF) and perhaps dopamine are inhibitory. Cholesterol supply to the gland may 
also be rate-limiting under certain circumstances. Sodium and potassium can affect 
both stimulatory and inhibitory pathways depending upon their relative dietary intake. 
For example, sodium restriction increases aldosterone synthesis, while sodium loading 
inhibits synthesis. The opposite is true of potassium. There are also a number of 
other factors (see later) which may influence secretion but whose exact physiological 
role remains uncertain.
1.6 The Renin-Angiotensin System.
The circulating renin-angiotensin system (RAS) plays a crucial role in the 
regulation of arterial blood pressure, renal haemodynamics and fluid and electrolyte 
balance. The proteolytic enzyme renin is synthesised and secreted from 
juxtaglomerular cells (located in the afferent arteriole of the kidney) in response to 
a number of factors including reduced extracellular volume, low concentrations of 
sodium in the glomerular filtrate, high dietary protein and sympathetic stimulation 
of juxtaglomerular cells (27,28). Within plasma, renin cleaves a decapeptide, 
angiotensin I, from the amino terminus of angiotensinogen, a 452 amino acid single 
polypeptide (29), which is released from the liver under the control of a number of 
factors including glucocortocoids, estrogens and thyroid hormones (30). When the 
two carboxy-terminal amino acids of angiotensin I are subsequently removed by 
angiotensin converting enzyme (ACE) on passage through capillary beds,
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The adrenal gland and zonal regulation of steroid synthesis.
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particularly in the lungs, a potent pressor agent, angiotensin II (A-II), is formed. 
Circulating A-II initiates a complex series of physiological events which work 
together to restore plasma volume, sodium concentration and blood pressure. These 
events include vasoconstriction, stimulation of catecholamine release, increased renal 
blood flow, thirst stimulation and inhibition of renin release (27). Circulating A-II 
is also a key factor in the control of aldosterone secretion. Recently, it has also 
become clear that local renin-angiotensin systems are present within many tissues 
(31,32). Certainly, individual components of such a system, adrenal renin and ACE, 
have been demonstrated to exist in the adrenal gland (33,34) and are known to 
respond to other physiological effectors of A-II secretion such as changes in 
electrolyte balance (35,36). Such a self-contained adrenal renin-angiotensin system 
may exert powerful autocrine and paracrine influences on steroid synthesis (37).
1.7 Stimulation of Aldosterone Synthesis by Angiotensin-II.
A-II increases the rate of aldosterone biosynthesis by increasing the rates of both 
the early (conversion of cholesterol to pregnenolone) and late pathways (conversion 
of corticosterone to aldosterone) (38).
Two classes of A-II receptor have been described in bovine, canine and human 
glomerulosa cells (39);a high affinity and a low affinity site. Rats possess high 
affinity sites only. Their relative numbers are modulated by electrolyte balance.
The A-II receptor in glomerulosa cells is coupled to at least two cell-signalling 
systems, the | polyphosphatidylinositol system and the adenylate cyclase system.
(39,40).
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.1 The Polyphosphatidylinositol System.
The binding of A-II to its receptor results in rapid activation of phospholipase C 
(PLC), a phosphinositide-specific phosphodiesterase. This enzyme catalyses the 
breakdown of phosphatidylinositol 4,5 bisphosphate (PIP2) to form the second 
messengers inositol(l,4,5) trisphosphate (IP3) and 1,2 diacylglycerol (1,2 DAG) 
(Fig. 1.6) (41). This phosphoinositide response to A-II can be enhanced by non- 
hydrolysable GTP analogues and is mediated by an as yet uncharacterised, pertussis- 
insensitive regulatory GTP-binding protein (G-protein), designated Gp (G-proteins are 
located within the plasma membrane and play a crucial role in signal transduction 
mechanisms by coupling occupied receptors to their associated effector systems). 
Both IP3 and 1,2 DAG appear to be elevated throughout the duration of A-II 
stimulation and each seems to be necessary for a normal physiological response (39).
IP3 formation is rapid, biphasic and is dependent upon A-II concentration (27). 
An early peak is observed within a few seconds of exposure to A-II, followed by 
a nadir at about 30 seconds and then a continuous increase which lasts for at least 
30 minutes (40). The sustained increase in IP3 is dependent upon extracellular 
calcium [Ca2*]# whereas the initial generation of IP3 is not (42). Both [Ca2+]0 and 
IP3 are essential for a sustained aldosterone secretory response. It has been 
demonstrated that IP3 is inactivated by successive dephosphorylations giving 
consecutively inositol 1,4 bisphosphate, inositol phosphate and finally inositol which 
can be used to replenish PIP2 (Fig. 1.7) (41). Alternatively, IP3 can first be 
phosphorylated by a 3-kinase to yield inositol 1,3,4,5 tetrakisphosphate and then 
dephosphorylated to give inositol 1,3,4 trisphosphate which may itself be further 
phosphorylated or dephosphorylated. After stimulation with A-II the rise in 
cytoplasmic free calcium concentration [Ca2+];, activates 3-kinase and more
Fig.1.6
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Metabolism of inositol phosphates. 
From (44), Berridge and Irvine, 1989.
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inositol 1,3,4 trisphosphate is converted into higher inositol phosphates. The 
significance of these higher inositol phosphates in glomerulosa cells, stimulated long­
term with A-II, is still unknown but they may be involved in steroidogenic control
The rate of 1,2 diacylglycerol (DAG) formation is similar to that of IP3 
production. Sustained DAG production in response to A-II is calcium-sensitive
(39,40). However, unlike IP3 formation, the sustained DAG response to A-II is not 
totally abolished by low [Ca2+]0 (42). This difference in [Ca2+]0 dependency between 
IP3 and DAG responses indicates that a substantial amount of DAG may be formed 
from sources other than PIP2. A-II has also been shown to stimulate phospholipase 
D activity which catalyses the breakdown of a variety of phospholipids to form 
phosphatidic acid which can then be readily converted to DAG (43). DAG can be 
removed by two metabolic pathways: either by conversion to phosphatidic acid for 
re-entry into the phosphoinositide cycle (44) or by hydrolysis which releases 
arachidonic acid (45). Arachidonic acid provides substrate for cycloxygenase and 
lipoxygenase enzymes, the products of which, including [thromboxanes and 
prostaglandins, have been implicated in steroidogenic control (see later).
1.7.2 The Adenylate Cyclase System.
This well-characterised signal transduction pathway (46) couples a receptor, via 
one of two main types of G-protein, Gg or G; to the enzyme adenylate cyclase 
(Fig. 1.8). Activation of Gs stimulates enzyme activity and activation of G; inhibits 
it. Adenylate cyclase activation results in production of cAMP which mediates its 
effect on cell function through activation of protein kinase A. In adrenal cells, A- 
II reduces both basal and stimulated production of cAMP through Gj, although at 
the present time this inhibitory effect has not been shown to be of physiological
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significance (39).
1.7.3 The Calcium Response to Angiotensin-II.
[Ca2+]j serves as a messenger during both the initiation and maintenance of an 
aldosterone secretory respose to A-II. The mechanism of messenger generation, the 
spatial domain in which the messenger operates and the molecular targets of calcium 
action differ between two temporal phases which are termed the initial phase and 
the sustained phase (39,40).
(i) Initial phase: There are intracellular binding sites in the ZG which are specific 
for IP3 and have a very low affinity for other inositol phosphates (27). In bovine 
cells, these binding sites are located on vesicles loosely attached to the plasma 
membrane, which contain stored calcium (39). Binding of IP3 to its receptor, a 
glycoprotein which requires binding of four IP3 molecules for activation, is followed 
by Ca2+ release through an opened membrane channel (47). In bovine glomerulosa 
cells, this transient rise in [Ca2^  achieves a maximum within 0.5 - 3min before 
falling to a sustained plateau which is still above basal levels (39). The initial 
calcium spike is sufficient to activate the Ca2+-binding protein calmodulin (48) which 
affects cell function by phosphorylating target proteins (see later).
(ii) Sustained Phase: After the initial response, [Ca2+]; remains only minimally 
elevated. It is widely accepted that the sustained phase of the Ca2+ signal is 
maintained by Ca2+ influx across the plasma membrane. However, there is some 
controversy concerning the participation of voltage-sensitive and insensitive 
mechanisms in this process.
The resting membrane potential of the glomerulosa cell is -70mv and is similar
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Dual control of adenylate cyclase by the regulatory proteins, Gs and G;.
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to that found in other types of excitable cell. This value is totally dependent upon 
the permeability of the cell membrane to K+ ions. Any decrease in membrane 
permeablity to this cation and the cell depolarises. Calcium channels which are 
activated by cell depolarisation, have been identified in plasma membranes of 
excitable cells. There is a large literature available on these voltage-sensitive calcium 
channels (VSCC) but in relation to this study only two types are relevant; the L- 
type and the T-type (49,50). Both have been identified in the bovine glomerulosa 
cell (51).
L-type channels have high Ca2+ conductance and a prolonged opening time but 
have a high threshold of activation (-30mv). They are the targets of calcium channel 
blockers such as the dihydropyridines nitrendipine and nifedipine.
T-type channels have lower activation thresholds (-60mv) than L-type channels but 
also have lower Ca2* conductance and a shorter opening time. They are insensitive 
to dihydropyridines but sensitive to catecholamines.
Of these two channel types, only T-type activation may be important in the 
glomerulosa cell since the L-channel activation threshold (-30mv) is too far from the 
resting membrane potential to be of physiological relevance (-70mv).
Following A-II stimulation, there is increased [Ca2+]0 uptake by the glomerulosa 
cell and this uptake is sensitive to pharmacological blockade by VSCC blockers such 
as the dihydropyridines (52). Electrophysiological evidence suggests that binding of 
A-II to its receptor leads to depolarisation of the glomerulosa cell by closing 
membrane potassium channels (53). This conclusion is supported by isotopic studies 
which measured potassium efflux in isolated bovine glomerulosa cells pre-loaded 
with 43K (54). Efflux was determined by measuring the radioactivity remaining in 
cells after the allocated incubation periods. Complex kinetic analysis of experimental
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data derived from these studies demonstrated that 43K efflux from glomerulosa cells 
could be divided into two components, a fast exchange component (t 1/2 approx. 15 
mins.) and a slow exchange component (t 1/2 approx. 48 mins.). A-II stimulation 
produced opposite effects on these two components, inhibiting efflux from the fast 
exchange component but stimulating efflux from the slow exchange component. 
These data support a model in which potassium channels close on receptor 
occupation, leading to membrane depolarisation and increased uptake of [Ca2+]e 
through VSCC. The increased [Ca2+]j concentration then allows opening of Ca2+- 
sensitive potassium channels (55,56), which have been identified in mouse Y-l 
adrenocortical cells (57), and the repolarisation of the plasma membrane.
In contrast, several reports have suggested that [Ca2+]0 uptake during the sustained 
phase of the A-II response occurs through dihydropyridine-insensitive mechanisms 
(40). Membrane Na+/K+ ATP’ase activity has been implicated in this process. A- 
II inhibits this ion transport system (58) thereby increasing intracellular Na+ 
concentration which, in turn, increases [Ca2*^  through increased Na+/Ca2+ exchange. 
However, given that Na+/K+ ATP’ase activity is also involved in potassium transport 
it is likely that A-II inhibition, like ouabain which is an inhibitor of Na+/K+ ATP’ase 
(58), would depolarise the cell, also inducing calcium influx.
Whether voltage sensitive or insensitive mechanisms of Ca2+ entry are more 
important during the sustained phase of A-II action is difficult to ascertain. Possibly 
a model involving both mechanisms is more accurate (40).
(iii) [Ca2+], oscillations: Oscillations of cytosolic Ca2+ have been observed in many 
cell types during hormonal stimulation and it has been suggested that these 
oscillations represent a process whereby initial agonist-stimulated release of calcium 
from an IP3-sensitive pool acts as a primer for further calcium release from IP3-
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insensitive pools, producing a calcium spike that spreads like a wave throughout the 
cell (59). Individual calcium responses of single glomerulosa cells to A-II have been 
examined using the calcium-chelating fluorescent dye, Fura-2 (60), monitored either 
by digital video or by microspectrofluorometric methods (39). In general, these 
studies have demonstrated the heterogeneity of the intracellular calcium response to 
A-II. In bovine and rat cells, the concentration of A-II used influences not only the 
lag-time preceeding the initial IP3-mediated Ca2* spike but also determines the 
frequency of subsequent [C a2+]j oscillations which merge to form peak plateau 
waveforms at higher hormone concentrations (Fig. 1.9). In the glomerulosa cell, it has 
been suggested that the frequency of oscillation governs the steroidogenic response 
(61).
1.7.4 Role of [Ca^], in Angiotensin-II-Stimulated Aldosterone Synthesis.
Increases in [Ca2+]j are thought to stimulate aldosterone synthesis by activating 
protein kinases, thereby altering cellular protein phosphorylation. The sequential 
production of different inositol phosphates and the complexity of the calcium 
message have led to the proposal that the protein kinases involved in the initial and 
sustained response of the glomerulosa cell to A-II may be different (39). 
Ca2+-activated Calmodulin: Many of the actions of calcium are mediated by 
calmodulin. The catalytic activity of this widely distributed | protein, which has been 
identified in the adrenal cortex, is calcium-dependent. Following a brief exposure to 
A-II, several cellular proteins become transiently phosphorylated through the actions 
of Ca27calmodulin-dependent protein kinase(s) (39). Some possible candidates for 
calmodulin action have been identified in the adrenal Y-l cell line and include 
several kinases and phosphatases (39). It has also been proposed that
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calmodulin alters cholesterol transport into the mitochondrion by modifying 
cytoskeletal architecture (27). Further evidence for a role for calmodulin in activating 
aldosterone synthesis comes from studies using the calmodulin inhibitors W7 and 
Calmidazolium (63). Both compounds markedly reduce A-II-stimulated synthesis in 
calf glomerulosa cells.
Protein Kinase C (PKC): PKC is a cytosolic enzyme whose activation requires two 
effectors (64), Ca2+ and DAG. Upon stimulation of bovine adrenocortical cells with 
A-II, PKC is translocated from the cytosol to the plasma membrane (65). This not 
only positions the enzyme in a phospholipid envirnoment, which enhances calcium 
binding (64), but also brings it into close proximity to high local concentrations of 
Ca2+ and DAG (66). In concert, Ca2+ and DAG induce PKC autophosphorylation, 
causing a conformational change in the enzyme that allows substrate binding and 
subsequent catalysis (64). It has been reported that during the sustained secretory 
response, there is a group of proteins which are phosphorylated after a 30 minute 
but not a 1 minute incubation period (39). It is likely that these phosphoproteins are 
substrates of PKC, since this pattern of phosphorylation can be reproduced by 
pharmacological agents, such as phorbol esters and Ca2+ ionophores, which substitute 
for A-II-induced DAG and Ca2+ influx respectively. Taken together, these data 
suggest that PKC mediates the sustained A-II induced elevation of aldosterone 
secretion whereas the A-II-elicited calcium transient mediates the initial response via 
activation of Ca2+/calmodulin-dependent proteins.
However, not all evidence points to a central role for PKC in the sustained 
aldosterone response. Membrane translocation of PKC has not been demonstrated in 
rat glomerulosa cells and the authors of recent studies in calf cells using inhibitors 
of PKC and Ca2+/calmodulin concluded that the latter factor is the critical mediator
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of both the initial and sustained phases of aldosterone secretion (63). Therefore a 
role for PKC in the control of aldosterone synthesis by A-II has yet to be 
confirmed.
1.7.5 Role of Mitochondrial calcium in Angiotensin-II-Stimulated Aldosterone 
Synthesis.
Changes in mitochondrial free calcium concentration may contribute directly to the 
regulation of the mitochondrial steroidogenic enzymes. There are reports that Ca2+ 
ions activate P-450scc(67) and P-450118 (27), although others claim that Ca2+ ions 
inhibit P-450^ (68). Mitochondrial calcium fluxes also affect the concentration of 
mitochondrial pyridine nucleotides which supply the reducing power for steroid 
biosynthesis (69). Recent work has demonstrated that A-II, whilst increasing [Ca2+], 
also lowers total mitochondrial calcium content (70). It is interesting to speculate 
that mitochondrial calcium may play a role not only in activation of steroidogenic 
enzymes but also in the control of cytosolic calcium.
1.8 ACTH Stimulation of Aldosterone Synthesis.
ACTH is synthesised in the pituitary under the control of corticotropin releasing 
factor, ANP and circulating glucocorticoids. It is undoubtedly the major regulator of 
inner zone adrenocortical function. However, its role in the physiological control of 
aldosterone secretion is less clear and administration of ACTH in vivo has been 
demonstrated to both increase and decrease aldosterone synthesis (27).
In vitro, ACTH is a most effective stimulus to aldosterone secretion giving a 
maximal response which is often greater than that of other glomerulosa stimulants
(71). The ACTH receptor is linked to adenylate cyclase and receptor occupation
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stimulates the enzyme to increase intracellular cAMP via a regulatory Gs protein. 
Raised levels of cyclic nucleotide then stimulate cAMP-dependent protein kinase 
which is located in the cytosol of the adrenocortical cell. This activated protein 
kinase phosphorylates several cytosolic and microsomal proteins. For example, the 
enzyme cholesterol ester hydrolase, when activated, increases the pool of intracellular 
free cholesterol (27). cAMP also has an effect at the gene level, promoting 
transcription of steroidogenic enzymes and their associated electron transport systems
(72).
It has been demonstrated that low concentrations of ACTH can also stimulate 
steroid synthesis in the absence of any measurable rise in cAMP (27). This may be 
explained by the discovery of two forms of ACTH receptor; a high affinity site and 
a low affinity site. It has been proposed that high concentrations of ACTH stimulate 
cAMP formation by activating the low affinity receptor, while low concentrations 
of ACTH acting via the high affinity receptor stimulate steroid synthesis by a 
mechanism less dependent on adenylate cyclase (27). The high affinity receptor may 
be coupled to the calcium messenger system. An intracellular calcium response to 
ACTH, albeit different to that elicited by A-II, has recently been demonstrated in 
both rat and bovine glomerulosa cells (73). In most cases, addition of ACTH leads 
to a slow increase in [Ca2+]j after a long-lasting delay period (10-15mins). This 
response is dependent on [Ca2+]0, is dihydropyridine-sensitive and is inhibited by 
blockers of cAMP-dependent protein kinase suggesting that the rise in [Ca2+]; induced 
by ACTH results from calcium influx through voltage-sensitive channels which need 
to be phosphorylated by cAMP-dependent protein kinase for full activation. Further 
evidence of a role for calcium in mediating steroidogenic responses to ACTH comes 
from work with murine Y-l tumour cells which showed that calmodulin inhibitors
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markedly reduced production of both steroids and cAMP in response to ACTH and 
forskolin. This would imply that the ACTH receptor, acting via Gs, can stimulate 
steroidogenesis through activation of Ca2+/calmodulin (74). Additionally, in rat and 
bovine cells, acute (mins) but not long-term (hours) exposure to ACTH increases 
intracellular DAG and induces PKC translocation to the plasma membrane, 
implicating a possible for phosphatidyl inositol metabolism in corticotropin action 
(27).
1.9 Effects of Eicosanoid Metabolites on Aldosterone Synthesis.
Both A-II and ACTH stimulate production of DAG (see above) which provides 
a common pathway through which both hormones may influence aldosterone 
secretion. DAG, released in response to hormonal stimulation, can be metabolised 
by two pathways. It can be converted to phosphatidic acid and then re-enter the 
phosphoinositide cycle (44) or it can be hydrolysed to release arachidonic acid (45). 
Arachidonic acid can be further metabolised by three pathways (75) (Fig. 1.9);
(a) The cyclo-oxygenase pathway giving prostaglandins (PG’s) and thromboxanes.
(b) The lipo-oxygenase pathway giving hydroxyperoxyeicosatetraenoic acids 
(HPTET’s), hydroxyeicosatetraenoic acids (HETE’s) and leukotrienes (LT’s).
(c) The cytochrome-P450 pathway giving epoxyeicosatrienoic acids (EET’s) 
dihydroxyeicosatrienoic acids and HETE’s.
Many studies indicate that arachidonic acid metabolites such as prostaglandins (76) 
and, more recently, the 12-lipoxygenase product 12-HETE (77,78) augment 
aldosterone production in the adrenal cortex. However, much of this work was done 
by using pharmacological inhibitors of the cyclo-oxygenase and lipo-oxygenase 
pathways rather than examining direct effects of prostaglandins and 12-HETE on
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steroid synthesis. Therefore a role for these metabolites in the regulation of 
aldosterone secretion remains controversial.
1.10 Potassium Ion Activation of Aldosterone Synthesis.
The glomerulosa cell is an extremely sensitive sensor of extracellular potassium 
such that small elevations in plasma potassium within the physiological range can 
induce significant increases, not only in aldosterone secretion but also in the 
expression of steroidogenic enzymes (79,80). Physiologically, the most important 
action of potassium on the glomerulosa cell is probably to affect its sensitivity to 
A-II (27); low plasma potassium concentrations decrease the aldosterone response 
to A-II and high plasma potassium increases it (39). The opposite is true for plasma 
sodium. This is consistent with aldosterone’s role in maintaining electrolyte balance; 
stimulation of sodium reabsorption and potassium excretion.
In vitro, potassium has a direct action on the glomerulosa cell. Electrophysiological 
studies have demonstrated that elevated extracellular potassium, [K+]0, triggers 
aldosterone secretion exclusively by depolarising the cell membrane and opening 
voltage-sensitive calcium channels (VSCC’s) (40). The involvement of these 
channels is substantiated by studies in which dihydropyridines were found to inhibit 
calcium influx rate, [Ca2+]j elevation and the aldosterone secretory response (81,82). 
It has been proposed that both the L and T-type VSCC’s are involved in mediating 
the potassium response and that the extent of their involvement is dependent upon 
membrane potential (83). However, considering that the threshold potential of the L- 
channel (-30mv) can hardly be attained not only in vivo but also with high 
potassium concentrations in vitro, their participation in the generation of the calcium 
signal is unlikely and it is probably the T-channels that mediate this response (40).
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In rat, the concentration of, [K+]0 is around 3.6mM. Stepwise increases induce 
stepwise elevations in [Ca2+]j and a corresponding increase in aldosterone secretion 
up to a maximum at around lOmM [K+]0. Above this concentration, although [Ca2+]; 
remains elevated, aldosterone production decreases, resulting in a bell-shaped dose- 
response curve and a loss in correlation between intracellular calcium and steroid 
synthesis (84). It is interesting to note that concentration of reduced pyridine 
nucleotides, which supply reducing power to steroidogenic enzymes, mirrors this 
aldosterone response to potassium (69). The increase in [Ca2+]j appears to mediate 
potassium-stimulated aldosterone synthesis principally through activation of 
calmodulin (63,85). It has also been suggested that potassium may activate PLC 
which is Ca^-sensitive, thereby inducing a moderate production of DAG and an 
increase in the activity of PKC (86). However, others have shown that potassium - 
stimulated [Ca2+]j elevation is independent of inositol phosphate formation and have 
concluded that potassium neither activates PLC directly nor secondarily (87). 
Translocation of PKC to the plasma membrane has not been observed in 
glomerulosa cells in response to potassium (65,88) and PKC inhibitors have little or 
no effect on potassium-stimulated aldosterone synthesis (63,85).
The role of cAMP in mediating a response to potassium is also questionable; small 
increases in cAMP or no response at all to elevated potassium have been reported 
(85,87).
1.11 ANP Inhibition of Aldosterone Synthesis.
ANP is synthesised and stored in atrial muscle cells and released in response to a 
variety of stimuli including high plasma sodium concentration, atrial tachycardia and 
atrial streching (27). The active peptide which is formed in the plasma by proteolytic
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cleavage from a pro-hormone (pro-ANP) has potent natriuretic, diuretic and 
vasodilatory properties (89). ANP decreases renin output and is a potent inhibitor of 
A-II, ACTH and K+-stimulated aldosterone secretion in vivo and in vitro (90,91,92). 
The exact mechanism of ANP action on the glomerulosa cell remains to be 
identified but a number of cellular events associated with ANP action have been 
observed including increased concentrations of intracellular cGMP (39), increased or 
decreased intracellular cAMP, decreased uptake of extracellular calcium and, in the 
longer term, adrenal atrophy (93,39).
1.12 Other Effectors of Aldosterone Synthesis.
There are many other factors which have been reported to influence adrenocortical 
function (27). Those agents which have a negative effect include dopamine and 
somatostatin while serotonin, noradrenaline, adrenaline, acetylcholine, vasopressin, 
a-MSH and vasoactive-intestinal peptide are claimed to be positive effectors. Most 
of these agents have yet to be shown to be physiologically important in the 
regulation of aldosterone. A detailed analysis of their actions is beyond the scope 
of this preliminary review.
1.13 Substrate Supply for Steroidogenesis.
The availability and delivery of cholesterol to the side-chain cleavage enzyme, 
located in the inner mitochondrial membrane of adrenocortical cells, is the major 
rate-limiting step in steroid biosynthesis (94,95). This substrate can be derived from 
a variety of sources (27):
(i) De novo synthesis from acetate.
(ii) Hydrolysis of stored intracellular cholesteryl esters.
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(iii) Uptake from circulating plasma lipoproteins.
The relative contribution of each source varies according to species and the overall 
rate of gland activity.
De novo synthesis: The synthesis of mevalonate from acetyl-CoA is the rate- 
determining step in this pathway and is catalysed by 3-hydroxy 3-methyl glutaryl 
CoA reductase (3HMG CoA reductase). The activity of this enzyme is regulated by 
ACTH and by feedback inhibition of intracellular cholesterol (96).
Hydrolysis of stored cholesteryl esters: Cholesterol is stored in esterified form 
within cytosolic lipid droplets (27). The interconversion of cholesterol ester and 
cholesterol is regulated by two enzymes; Acyl CoA cholesteryl acyltransferase 
(ACAT) and cholesterol ester hydrolase (CEH). CEH is known to be phosphorylated 
and activated in response to ACTH stimulation (97). The concentration of cholesterol 
which is available for steroidogenesis (ie-free cholesterol) is dependent upon the 
quantity and relative activity of these two enzymes.
Uptake of circulating lipoproteins: Cholesterol, triacylglycerols and other lipids are 
transported in body fluids by a series of lipoproteins classified according to their 
density. These lipoproteins consist of a core of hydrophobic lipids surrounded by 
polar lipids and then by a shell of apoproteins. Many of the apoproteins have been 
characterised and shown to carry the signal sequence that receptors on the 
appropriate target cell recognise (98).
Low-density lipoprotein (LDL) is rich in cholesterol, most of which is esterified 
to the polyunsaturated fatty acid, linoleate. In most species LDL appears to be the 
primary source of cholesterol and is metabolised by the following pathway 
(99)(Fig.l.lO):
(i) LDL binds to specific receptors in the plasma membrane.
52
(ii) The receptor-LDL complex is internalised by endocytosis.
(iii) The cholesteryl esters are hydrolysed by lysosomal enzymes.
(iv) Free cholesterol is used for steroid synthesis or re-esterified by ACAT and 
stored in cytosolic lipid droplets.
This pathway regulates cellular cholesterol concentration in two ways. Firstly, 
released cholesterol supresses de novo synthesis by feedback inhibition of HMG 
CoA reductase and secondly, the LDL receptor is down-regulated by cholesterol.
Whereas LDL is responsible for the bulk of extracellular cholesterol transport to 
peripheral tissues, high density lipoprotein (HDL) exerts its main physiological role 
on reverse cholesterol transport, a process in which cholesterol from peripheral 
tissues is transported back to the liver for catabolism and excretion (100). This 
process is essential for homeostasis as most cells cannot metabolise any cholesterol 
that is accumulated. Steroidogenic cells are a notable exception. They can use both 
LDL and HDL-cholesterol. The mechanisms involved in HDL binding and transport 
of cholesterol to and from cells are complex and have not yet been fully elucidated. 
Two components appear to be involved. Firstly, a high affinity, saturable cell surface 
component which may interact with HDL apoproteins A-I, A-II (101) and E (102) 
and secondly, a lower affinity, non-saturable exchange component which seems to 
be a process of simple bidirectional diffusion of cholesterol between lipoprotein and 
cell membrane (100). The uptake pattern of the different lipoproteins by the adrenal 
cortex is complex and exhibits not only species specificity (103), but may also vary 
between zones (104). In vivo studies indicate an important role for LDL in the 
sustained supply of cholesterol to the bovine and human adrenal cortex whereas 
HDL is the prefered donor in the rat (99,105). However, recent work has suggested 
that acute (lh) cholesterol requirements for steroidogenesis may also be met by HDL
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in incubations of bovine glomerulosa and human granulosa cells (103,106).
1.13.1 Cholesterol Transport in the Adrenocortical Cell.
Cholesterol transport from cytosol to the inner mitochondrial membrane can be 
considered in two steps, both of which are accelerated by ACTH (107). The first 
process is cycloheximide-insensitive and involves transport to the outer mitochondrial 
membrane. Integrity of the cell cytoskeleton seems to be important since inhibitors 
of microtubule and microfilament formation, such as cytochalasin B, inhibit adrenal 
steroidogenesis (27). The second step is the transfer of cholesterol from the outer 
to the inner mitochondrial membrane. Despite the fact that a knowledge of this 
process is essential to the understanding of steroidogenic regulation, neither its 
mechanism of action nor the functional components involved have been positively 
identified. Intra-mitochondrial transport is cycloheximide-sensitive (108). It is 
proposed that a protein(s) with a rapid turnover rate is required to mediate this 
cholesterol translocation and that stimulatory hormones may either increase the level 
of or activate this protein (27). A number of peptides have been identified as 
potential candidates. Hepatic sterol carrier protein 2 (SCP2) enhances intra- 
mitochondrial transport, reversing the effects of cycloheximide (109) and a protein 
similar to hepatic SCP2 , which is inducible by ACTH, has been identified in the 
adrenal gland (110). Another cycloheximide-sensitive protein, termed protein i (MW 
28000), has also been identified in adrenocortical cells (111). Protein i is produced 
in response to ACTH with a time-course and dose-dependency which parallels the 
steroidogenic response. A third peptide (MW 2200) has been identified in rat 
adrenals which is induced by ACTH and which stimulates side-chain cleavage 
activity (112,113).
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1.13.2 Endozepines and Benzodiazepines.
Recently a new group of proteins, the endozepines or diazepam binding inhibitors, 
have been proposed as the endogenous regulators of intra-mitochondrial transport 
(114). These claims originated from studies of the steroidogenic effects of a group 
of tranquillising drugs, called the benzodiazepines. Benzodiazepines are widely used 
as anxiolytic and anticonvulsant drugs (115). Specific binding sites in the central 
nervous system (CNS) appear to mediate their physiological action through the 
activation of the| y- aminobutyric acid (GABA) receptor (116,117). In addition, 
binding sites for benzodiazepines have been identified in many peripheral tissues and 
these sites are pharmacologically distinct from the receptors in the CNS (118). 
Peripheral binding sites are found in the outer mitochondrial membrane and have 
been designated mitochondrial benzodiazepine receptors (MBR’s) (119). They have 
been identified in many tissues including heart, lung, kidney and in endocrine tissues 
such as the testis and the adrenal cortex (118,119). Since there appeared to be no 
correlation between MBR density and the activities of constitutive mitochondrial 
enzymes, it has been suggested that these receptors are required to fulfil a more 
specialised physiological function in the adrenal gland and testis, perhaps relating to 
control of steroidogenesis (120). Drugs selective for the MBR produce a spectrum 
of pharmacologic actions including alterations of immune function, cell proliferation 
and cardiac action potential (121). Of relevance to this review, a variety of MBR 
ligands (eg. diazepam and R05-4864) enhance corticosteroid synthesis in cultured 
rat and bovine ZF/R cells (122). Thus, MBR may be a target for endogenous ligands 
which mediate the action of steroid-stimulating hormones (114). Proteins which 
inhibit the benzodiazepine, diazepam from binding to CNS receptors (114) have been
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purified to homogeneity from bovine, human and rat brain (123) and have been 
termed endozepines or diazepam-binding inhibitors (DBFs). Native DBI fragments 
when added to cholesterol loaded Y-l mitochondria produce a dose-dependent 
stimulation of pregnenolone formation which can be antagonised by flunitrazepam 
(114) implicating the MBR.
Immunocytochemical and biochemical studies have demonstrated the presence of 
DBI and DBI-like peptides in the periphery with notably high concentrations 
identified in the adrenal cortex (124). Des-[gly-ile]-DBI has been isolated from 
bovine ZF/R cells and been shown to stimulate pregnenolone formation in 
cholesterol-loaded adrenocortical mitochondria in a manner similar to diazepam 
(114,123). Thus both may operate through the same effector system, the MBR 
(Fig.1.11). Spectral-shift assays showed that addition of Des-[Gly-Ile]-DBI to 
mitochondria also increased substrate-bound fraction of P-450^ in the absence of 
added cholesterol (123). This implies that the peptide may not only influence 
mitochondrial translocation but may also mobilise inner membrane cholesterol. If 
DBI are involved in steroidogenic regulation then their synthesis and activity should 
be under hormonal control. In vivo studies done with hypophysectomised rats 
demonstrated that administration of ACTH increased adrenal DBI immunoreactivity 
(125). This increase was blocked by cycloheximide suggesting that DBI synthesis 
was under the control of ACTH. Conversely, pulse-chase experiments performed 
with ^S-methionine in Y-l and LH10 cell lines, failed to show any effects of 
hormonal stimulation (ACTH for Y-l cells, LH for LH10 cells) on DBI synthesis 
or turnover, although steroid synthesis was significantly stimulated (126). It may be 
that, in vitro, hormone action is directed at DBI-receptor interaction, possibly through 
receptor phosphorylation, rather than regulating DBI activity and synthesis directly.
Fig. 1.11
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Such a mechanism would still require DBI for control of steroidogenesis but 
without the neccesity for any increase in synthesis of the peptide (126).
As yet there is no direct evidence to show that DBI or related proteins are the 
short-lived, cycloheximide-sensitive factors which regulate aldosterone synthesis. In 
any case, cholesterol translocation is probably more complex than previously 
suspected, involving multiple transport mechanisms regulated by more than one 
protein over different time courses (127).
1.14 Project Aims.
The present study has used a number of benzodiazepine ligands, in particular 
diazepam, to examine the effects of DBI’s on aldosterone synthesis in bovine 
adrenocortical cells.
Benzodiazepines are metabolised by cytochrome P-450 enzymes in the liver and 
other drugs which are similarly metabolised are potent inhibitors of steroidogenic 
enzymes. For example, dantrolene which has been used in signal transduction studies 
as a specific inhibitor of IP3-mediated calcium release, interferes strongly with P- 
450^ (See chapter 2). These drugs also affects depolarisation-induced calcium influx 
in other excitable cell types. Therefore it was decided to characterise the effects of 
benzodiazepines in three areas of adrenocortical cell function:
(i) Interaction with steroidogenic enzymes.
(ii) Mobilisation of extracellular calcium.
(iii) Cholesterol-stimulated aldosterone synthesis
All studies were carried out in bovine whole cells and mitochondria. A readily- 
available source of cholesterol was necessary and HDL was chosen. However, as 
reports in other systems had suggested that HDL-target cell interaction may be
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associated with alterations in cell calcium metabolism, this possibility had to be 
excluded in adrenocortical cells.
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CHAPTER 2.
EFFECTS OF DANTROLENE ON ADRENAL STEROIDOGENIC ENZYMES.
2.1 Introduction
When using supposedly specific drugs to investigate cell function it is important 
to realise that they may have more than one mode of action. For example, proposed 
modes of action for benzodiazepines include effects on mitochondrial cholesterol 
transport and on cell calcium metabolism (122,128). When investigating 
adrenocortical cell function it is quite likely that drugs interact with steroidogenic 
cytochrome P-450 enzymes in the same way that they would be metabolised by 
mixed fuction oxidases in the liver. One such compound is the skeletal muscle 
relaxant dantrolene. This drug, widely used in the treatment of muscle spasticity, 
exerts its therapeutic effect by inhibiting the release of calcium from the 
sarcoplasmic reticulum (129). This property has made dantrolene an obvious tool to 
study the role of calcium in mediating hormone action (130,131). However, adverse 
clinical effects, most notably hepatic injury, have been reported following treatment 
with a high daily dose of the drug (132). This liver damage was associated with 
direct inhibition of hepatic, cytochrome P-450 enzymes (133,134). Since dantrolene 
had been demonstrated to inhibit glucocorticoid secretion in vivo (135), I decided 
to investigate whether the drug affects steroidogenesis in vitro other than by 
inhibiting intracellular calcium release and, if so, whether key cytochrome P-450 
dependent mitochondrial steps are affected.
2.2 Materials and Methods
Unless stated otherwise all reagents were obtained from the Sigma Chemical
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Company, Poole, Dorset.
(i) Isolation of Adrenocortical Cells.
Six adrenal glands taken from freshly slaughtered cattle were obtained at a local 
abattoir. Thin slices of tissue were taken from the outer regions of these defatted 
glands and minced. They were then subjected to collagenase digestion (1.5mg/ml; 
Worthington Biochemical Corp., N.J., U.S.A.) with mechanical agitation in Kreb’s 
bicarbonate Ringer’s solution (NaCl 120.6 mmol/1, NaHC03 24.8mmol/l, KC1 
2.6mmol/l, MgS04 1.15mmol/l, CaCl2 2.54mmol/l and KH2P04 1.15mmol/l) 
containing 10mmol/l glucose and bovine serum albumin (20g/l). The resulting cells 
were filtered twice , firstly through a tea strainer and then through 100pm gauze 
(Henry Simon Ltd, Stockport) before being applied to a discontinuous gradient of 
isotonic Percoll (Pharmacia LKB, Uppsala, Sweden). Following centrifugation (10 
min., 2800g) the cells with specific gravity >1.039 and <1.052 were resuspended in 
medium 199 (Gibco Ltd, Paisley, Scotland), modified so that the ionic composition 
was the same as that of the Ringer’s solution, and containing 10mmol/l glucose and 
BSA (2g/l). It has been demonstrated previously that, although these preparations are 
enriched with aldosterone-producing zona glomerulosa cells, they do contain 
significant ammounts of zona fasiculata/reticularis cells (136). The final concentration 
of cells used in the following experiments was approximately 3x10? cells/ml.
(ii) Isolation of Adrenocortical Mitochondria
Thin slices were removed from the outermost region of bovine adrenal glands. 
Adrenocortical tissue was scraped from the capsule and homogenized (3x10s.) using 
a Polytron PTA20S homogenizer (Kinematic, Denmark) in ice-cold 0.25mol/l 
sucrose, pH 7.2, containing triethanolamine hydrochloride (10mmol/l),
ethylenediaminotetra-acetic acid (0.1mmol/l) and BSA (10g/l). The homogenate was 
centrifuged at 600g for 10 min. to remove cellular debris and the supernatant 
centrifuged at lOOOOg for 10 min. The pellet was then washed twice by resuspending 
in sucrose and recentrifuging. Mitochondria were not subject to further purification 
and so preparations may have included contamination from other sources eg-plasma 
membrane. Finally, prior to incubation, the mitochondria were suspended in 
0.25mol/l sucrose, pH 7.1, containing KC1 (20mmol/l), triethanolamine hydrochloride 
(15mmol/l), MgCl2 (5mmol/l) and BSA (10g/l) at a concentration of 3-15mg 
protein/ml (137).
(iii) Steroid Incubations 
Cell and mitochondrial suspensions (0.5ml) were incubated in sextuplicate in 1.5ml 
microcentrifuge tubes at 37°C in an atmosphere of 95% O* 5% C 02 in medium 199 
(cells) or sucrose solution (mitochondria) containing dantrolene and/or various 
steroids. The steroids used in these experiments, 20a-hydroxycholesterol, 
pregnenolone, progesterone, 11-deoxycorticosterone, corticosterone, 18- 
hydroxy corticosterone and 11-deoxycortisol (dissolved in methanol), were added to 
the appropriate tubes and the solvent allowed to evaporate prior to the addition of 
incubation medium. The reactions were initiated by the addition of cells, or for 
mitochondrial incubations, by the addition of a solution composed of sodium 
succinate (2.5mmol/l), isocitrate (5mmol/l) and NADP+ (0.16mmol/l). Reactions were 
stopped after lh for cells by transferring tubes to ice-cold water. The cell 
suspensions were centrifuged at 800 g for 10 min. at 4°C and the supernatant stored 
at -20°C for later analysis. Mitochondrial reactions were stopped after 15 min. by 
dilution with methanol (1:20) prior to storage.
(iv) Steroid Assays
Steroids were measured by direct radioimmunoassay. All samples from each 
experiment were analysed in one assay. The coefficients of variation were 13.2%, 
14% and 8.7% for aldosterone, cortisol and pregnenolone assays respectively.
(a) Aldosterone assay: Duplicate assay standards were made up in lOpl methanol 
(0.31, 0.62, 1.25, 2.5, 5, 10, 20 and 40pg aldosterone/1 Opl) together with a volume 
of medium 199/sucrose solution equal to that of the samples. Sample tubes contained 
lOpl methanol plus incubation medium. Aldosterone antiserum ( a gift from Prof. 
Th. J. Benraad, Division of Endocrinology, Dept of Internal Medicine, University of 
Nijmegen, The Netherlands) was diluted 1:300000 in Borate buffer (boric acid 
0.13mol/l, sodium hydroxide 0.068mol/l and hydrochloric acid 0.05mol/l), pH 7.5, 
containing 0.1% y-globulin and 18Bq/100ml of the aldosterone conjugate, 
aldosterone-3-(o-carboxymethyl)oximino-(2-[125I]iodohistamine) (Amersham 
International, Amersham, Bucks). Antiserum mixture (200pl) was added to both 
standards and samples. The assay was left at room temperature for 1 hour and then 
overnight at 4°C. Charcoal solution (0.5% Dextran T-70 and 0.5% methanol-washed 
charcoal in borate buffer, pH7.5) at 4°C was added to each tube (150pl), mixed well 
and centrifuged at 2000g for lOmins. Supernatants were aspirated from all tubes 
and the radioactivity in the free fraction measured using a gamma scintillation 
spectrometer.
(b) Cortisol assay: Duplicate assay standards were made up in lOOpl of borate 
buffer (7.8, 15.6, 31.2, 62.5, 125, 250, 500 and lOOOpg/lOOpl) together with a 
volume of medium 199/sucrose solution equal to that of the samples. Sample tubes 
contained lOOpl borate buffer plus incubation medium. Cortisol antiserum (Scottish 
Antibody Production Unit, Law Hospital, Carluke, Lanarks., Scotland) was diluted 
1:20000 in borate buffer containing 0.1% ! y-globulin and 60KBq/100ml of the
cortisol conjugate, cortisol-3-(o-carboxymethyl)oximino-(2[,25I]iodohistamine)
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(Amersham International, Amersham, Bucks.). Antiserum mixture (150pl) was added 
to all tubes, the contents mixed and the incubations and charcoal separations 
performed as above.
(c) Pregnenolone Assay: Duplicate assay standards were made up in lOOpl methanol 
(6.25, 12.5, 25, 50, 100, 200, 400, 800 and 1600pg/100pl) together with a volume 
of sucrose/methanol equal to that of the samples. Sample tubes contained lOOpl 
methanol plus sucrose/methanol incubation medium. [3H] pregnenolone (3000cpm in 
lOOpl methanol) and ethylene glycol solution (l%vol/vol in methanol, 100 pi) were 
added to all tubes and the incubations evaporated to dryness at 37°C under a 
continuous stream of nitrogen. Antiserum to pregnenolone (138), was diluted 1:5000 
in borate buffer (containing 0.5% wt/vol fif-globulin and 2% vol/vol methanol) and 
500pi added to each tube. After overnight incubation at 4°C, dextran-coated charcoal 
(0.188% Dextran T-70 and 0.188% methanol-washed charcoal) was used to separate 
bound and free radioactivity. Supernatant (bound fraction) was then removed from 
each sample (500pl), added to 10ml Ecoscint A (National Diagnostics, Manville, 
N.J., U.S.A.) and counted for 10 mins. in a liquid scintillation spectrometer.
Data were compared by analysis of variance using the Newman-Keuls multiple range 
test (139) or by unpaired t-tests where indicated.
23 Results
(i) Effects of dantrolene on basal and A-II-stimulated aldosterone synthesis in 
isolated adrenocortical cells.
Figure 2.1 shows aldosterone output in basal and All-stimulated cells in the 
presence of increasing concentrations of dantrolene; 0.02mmol/l reduced and 
0.2mmol/l abolished the aldosterone response to A-II (P<0.01).
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(ii) Effects of dantrolene on aldosterone and cortisol synthesis from added precursors
in isolated adrenocortical cells.
The effects of the same concentrations of dantrolene on aldosterone synthesis in 
cells incubated in the presence and absence of hydroxycholesterol is shown in Fig. 
2.2. In the absence of hydroxycholesterol, inhibition of aldosterone synthesis was 
slight and only reached significance (P<0.05) at the highest concentration of 
dantrolene (0.2mmol/l). In the presence of hydroxycholesterol, aldosterone synthesis 
was inhibited at all concentrations of dantrolene in a dose-dependent manner 
(P<0.01; ICso value approx. 0.02mmol/l). However, aldosterone synthesis was still 
greater than controls when cells were treated with the highest concentration of 
dantrolene (0.2mmol/l).
The effects of dantrolene (0.2mmol/l) on aldosterone synthesis in cells which were 
incubated with various biosynthetic intermediates are shown in Fig. 2.3. Results are 
expressed as a percentage of controls (i.e. aldosterone synthesised in the absence of 
dantrolene). Control values (pmol/106 cells/h) were 70±5, 250±13, 356±19, 942±39, 
667±36 and 65±3 for cells incubated with hydroxycholesterol, pregnenolone, 
progesterone, 11-deoxycorticosterone, corticosterone and 18-hydroxycorticosterone 
respectively. In all cases dantrolene significantly inhibited aldosterone synthesis 
(PcO.Ol). The greatest percentage inhibition by the drug was in cells exposed to 
hydroxycholesterol (89%) and the least inhibition was with 18-hydroxycorticosterone 
(28%).
Figure 2.4 shows the effects of dantrolene on cortisol synthesis. The cells used in 
this experiment were the same as those in Fig. 2.3. Cortisol production was 
2.27±0.16, 3.99±0.19 and 6.5±0.32 nmol/106 cells/h for control cells incubated with 
hydroxycholesterol, pregnenolone and progesterone, respectively. Dantrolene only
inhibited cortisol production in cells exposed to hydroxycholesterol (89%, P<0.01).
(iii) Effects of dantrolene on aldosterone and cortisol synthesis from added 
precursors in isolated adrenocortical mitochondria.
Mitochondrial conversion of added hydroxycholesterol to pregnenolone and of 
added corticosterone and 11-deoxycortisol to aldosterone and cortisol were inhibited 
by dantrolene (PcO.Ol; Fig.2.5). Control steroid production values (pmol steroid/mg 
protein/15 min) from mitochondria not treated with dantrolene were 1166±150 for 
pregnenolone, 57±1 and 5±0.3 for aldosterone with added corticosterone and 18- 
hydroxycorticosterone, respectively and 12880±550 for cortisol from added 11- 
deoxycortisol. However, it must be emphasised that these results were obtained with 
only partially purified mitochondria.
2.4 Discussion.
In agreement with previous reports (140) my studies show that dantrolene inhibits 
All-stimulated steroid synthesis. Is this inhibition due to prevention of calcium 
release from intracellular stores or to some other calcium-independent process? In 
the case of adrenal steroidogenesis, a dantrolene-sensitive component of calcium 
mobilisation in response to All has been identified (141,142). It has also been noted 
that plasma glucocorticoid levels are reduced in vivo by dantrolene (135). 
Glucocorticoid synthesis is controlled predominantly by ACTH via an intracellular 
mechanism which does not involve phospholipase C activation and IP3-induced 
calcium release ((143); see Chapter 1). My study confirms in vivo findings that 
dantrolene can inhibit steroidogenesis by a mechanism which is not necessarily 
dependent upon Ca2+. Whether the mechanisms of in vitro and in vivo inhibition are 
the same is not clear. Therapeutic plasma concentrations of dantrolene are in the 
range 75-530nmol/l (144). These concentrations would not inhibit steroidogenesis
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using the protocol of the present in vitro studies. It is nevertheless possible that 
dantrolene is accumulated by adrenocortical tissue during long-term treatment.
Several experimental results show that the effects of the drug in vitro represent 
more than a block of agonist-induced calcium release. Both aldosterone and cortisol 
formation from added hydroxycholesterol were inhibited; there were also differences 
in the patterns of aldosterone inhibition between A-II and hydroxycholesterol-treated 
cells. The threshold concentration for dantrolene’s effects appeared lower in 
hydroxycholesterol-treated cells. In contrast, the highest concentration of dantrolene 
(0.2mmol/l) used here completely inhibited the effects of All but not those of 
hydroxycholesterol. These results are compatible with the hypothesis that dantrolene 
interferes with two steroidogenic processes, calcium mobilisation as well as a direct 
inhibition of one or more enzymes in the steroidogenic pathway.
To determine the site of this latter action, cells were incubated with different 
steroid precursors. Expressed in relative terms, the greatest effect of dantrolene was 
on cells treated with hydroxycholesterol. It is perhaps significant that aldosterone 
synthesis, which is regulated at two sites (cholesterol side-chain cleavage and 
conversion from corticosterone) (38), was inhibited in cells incubated with a variety 
of precursors whereas cortisol synthesis, which is regulated by the rate of cholesterol 
side-chain cleavage, was inhibited only when hydroxycholesterol was used as 
substrate. Taken together, these results suggest that dantrolene affects two 
steroidogenic control steps (cholesterol side-chain cleavage and conversion of 
corticosterone to aldosterone) both of which occur in the mitochondria and are 
calcium-dependent (145). One possible explanation of these results is that dantrolene 
blocks both aldosterone and cortisol synthesis by affecting calcium influx across the 
mitochondrial membrane. Accordingly, dantrolene was tested on isolated
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mitochondria. In the absence of added calcium, conversion of hydroxycholesterol to 
pregnenolone was inhibited, as was the synthesis of aldosterone from corticosterone. 
Although in intact cells, dantrolene did not affect cortisol synthesis from 
deoxycortisol, 116 hydroxylase activity in isolated mitochondria was profoundly 
inhibited. These data point to an action of dantrolene which is independent of 
acknowledged, signal-response coupling processes. Inhibitory actions of several drugs 
on cytochrome P450-dependent steroid hydroxylation reactions have been described 
in various tissues (146,147). These drugs are also metabolised by cytochrome P450 
enzymes in the liver. Since dantrolene is known to be a competitive inhibitor of 
hepatic P450 enzymes (133), the drug may bind to and inhibit adrenal steroidogenic 
enzymes in a similar way.
To summarise, dantrolene has an inhibitory effect on steroid synthesis in 
adrenocortical cells and in isolated mitochondria which is independent of its effects 
on intracellular calcium. The most likely explanation of this effect is competitive 
inhibition by the drug of cytochrome P450-dependent hydroxylase enzymes of the 
steroid biosynthetic pathway. In particular cholesterol side-chain cleavage activity, 
which catalyses the important rate-limiting conversion of cholesterol to pregnenolone, 
is sensitive to dantrolene. These data do not deny that dantrolene blocks All­
stimulated, IP3-mediated calcium mobilisation. However, caution is needed in 
interpreting experiments in which steroid measurements are used as an end-point 
when dantrolene, or indeed any class of drug metabolised by hepatic P-450 enzymes 
is used specifically to study signal transduction in steroidogenic tissues. For example, 
4-aminopyridine and cromakalim, two drugs which have known effects on potassium 
channel function, have, in addition, both been shown to inhibit adrenocortical steroid 
hydroxylation (148,149).
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CHAPTER 3.
EFFECTS OF HIGH DENSITY LIPOPROTEINS ON STEROID SYNTHESIS.
3.1 Introduction.
There are three sources of substrate (cholesterol) for steroidogenesis; (i) de novo 
synthesis from acetate, (ii) hydrolysis of intracellular stored cholesteryl esters or (iii) 
uptake from circulating plasma lipoproteins, principally low or high density 
lipoproteins (LDL or HDL). LDL is responsible for the bulk of cholesterol transport 
in blood and delivers cholesterol to tissues intracellularly via apolipoprotein B/E 
receptor-mediated endocytosis. HDL exerts its main physiological role by reverse 
cholesterol transport, a process critical for homeostasis, whereby cholesterol is 
transported by HDL from peripheral tissues back to the liver for catabolism and 
excretion. Apart from the liver, steroidogenic tissues are the only ones which 
metabolise significant amounts of cholesterol and HDL-cholesterol has been 
demonstrated to be used as a substrate for steroidogenesis in vivo and in vitro (100). 
However, the relative dependency of the adrenal cortex on these different 
lipoproteins is complex and exhibits not only species specificity (105) but also 
differs between zones of the gland (104). For example, in vivo studies have 
indicated an important role for LDL in the sustained supply of cholesterol to bovine 
adrenal cortex (99) whereas HDL is the prefered donor in the rat (105). LDL or 
HDL utilisation may also vary with time course of experiment. Recent work has 
suggested that HDL may be the prefered source of steroidogenic substrate in acute 
in vitro incubations of bovine cells whereas long-term cultures have identified that 
LDL-cholesterol may be used (103).
I have investigated the role of HDL-cholesterol in adrenocortical steroidogenesis
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in more detail by comparing the effects of two HDL subfractions, HDL-2 
(cholesteryl-ester rich containing apolipoprotein E) and HDL-3 (smaller, denser 
predominant plasma type containing a higher proportion of free cholesterol) on both 
basal and angiotensin II (A-II)-stimulated aldosterone and cortisol synthesis. These 
effects have been compared acutely (lh) in freshly isolated bovine adrenocortical 
cells and longer term (24h) in cultured cells.
Previous work in this laboratory ( H.D Simpson, unpublished data) demonstrated 
that unfractionated HDL reduces vasopressin-stimulated platelet aggregation by 
inhibiting AVP-induced increases [Ca2+]j. In addition, HDL-2 and HDL-3 treated 
platelets accumulated less 45Ca than appropriate controls when 45Ca uptake was 
measured both acutely (<2mins) and under steady-state conditions (>30 mins) (D. 
Graham, unpublished data). As aldosterone synthesis is notably calcium-sensitive (see 
chapter 1), these data raised the possibility that, in addition to supplying cholesterol, 
HDL could affect basal and hormone-stimulated steroidogenesis by affecting calcium 
metabolism. Therefore, I examined the effects of HDL-2 and HDL-3 on 45Ca uptake 
in freshly isolated zona glomerulosa cells. In addition, I investigated the effects of 
both subfractions on basal and A-II stimulated [Ca2*^  concentration in cells which 
had been in culture for 72h.
3.2 Materials and Methods.
Unless otherwise indicated all reagents were purchased from the Sigma Chemical 
Company, Poole Road, Dorset.
(i) Isolated Adrenocortical Cells.
Bovine adrenocortical cells were prepared according to the method described in 
Chapter 2 with the exception that Ham’s F-12 medium (Gibco BRL, Paisley,
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Strathclyde), containing 2.5mmol/l Ca2+ and 0.2% BSA, was substituted for Medium 
199 both in cell preparation and in experiments involving measurements of steroid 
synthesis.
Aliquots of cells (n=6, 2xl05cells/ml) were incubated together with A-II and/or 
HDL-2 and/or HDL-3 in an atmosphere of 95% 0 2 and 5% CO* at 37°C for lh. 
After incubation the cells were centrifuged (800g, 4°C for 10 mins.) and the 
supernatants removed and stored for later measurement of aldosterone and cortisol 
by direct radioimmunoassay (see chapter 2).
HDL subfractions were prepared by Dr. Muriel Caslake, Dept. Pathological 
Biochemistry, Royal Infirmary, Glasgow according to the method based on that of 
Havel et al (150). Briefly, HDL-2 (1.063-1.125g/l) and HDL-3 (1.125-1.21g/l) were 
seperated from human serum by repeated ultracentrifugations, after progressively 
raising solvent density of the serum by the addition of a concentrated salt solution. 
The total cholesterol content of the HDL subfractions was then measured by an 
enzymatic colorimetric method (151) according to instructions from and with 
reagents provided by the Cholesterol C-System assay kit (BCL Ltd, Lewes, East 
Sussex).
(ii) Cultured Adrenocortical Cells 
Following dispersal and Percoll separation the cells were resuspended in modified 
Ham’s F-12 plus 10% fetal calf serum containing the following additions; 50pmol/l 
butylated hydroxyanisole, 1.2pmol/l a-tocopherol, 100pmol/l ascorbate, 50nmol/l 
sodium selenite, 300nmol/l glutathione, lOng/ml insulin, lOpg/ml bovine transferrin, 
5pmol/l metyrapone, 2.5mmol/l Ca2+, 4mmol/l NaHC03 and 25mmol/l HEPES (152). 
The cells were then seeded into 24 well culture plates (Gibco BRL, Paisley,
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Strathclyde) at a concentration of 1 Odells per well. After 5 days in culture, HDL- 
2 and HDL-3 were added to appropriate wells. On day 6 the plates were washed 
three times with serum-free Ham’s F-12 containing only 2.5mmol/l Ca2+ and 0.2% 
BSA and incubated in the same medium in the presence of appropriate 
concentrations of A-II and/or HDL-2 and/or HDL-3 in an atmosphere of 95% 0 2 and 
5% C02 at 37°C for 3 hours. The supernatant was then removed and stored for 
steroid analysis.
Preliminary work had demonstrated that adrenocortical cells achieved confluence 
after six days and that these cells were then very responsive to A-II (see Fig.3.1).
(iii) 4SCa Uptake Studies
45Ca uptake was measured using a modification of the method of Mauger, Poggioli, 
Guesdon and Claret (153). Cells (approximately 8x10s per incubation) were 
preincubated at 37°C for 30 min. in Krebs’ bicarbonate-Ringer containing 0.2% 
glucose and BSA (KRBGA) and lmmol Ca271. This ensured that measurements of 
cells were not depleted of calcium prior to 45Ca studies. HDL-2 or 3 was then added 
and cells were incubated for a further 15min. Following addition of 17kBq 45Ca 
(Amersham International pic, Amersham, Bucks.) in KRBGA containing lmmol/1 
Ca2+ (specific activity of the final incubation mixture was 170MBq/mmol), aliquots 
of suspensions were sampled at appropriate time-points. The cells were collected 
onto glass fibre filters (GF/C; Whatman International Ltd, Maidstone, Kent) using 
a Titretek Multi-channel Cell Harvester (Flow Laboratories, Irvine, Strathclyde) and 
washed for approximately 30s with ice-cold 5mmol Tris buffer/1 (approximately 
14ml) containing 144mmol/l NaCl and 5mmol/l CaCl2. The filters were then 
transferred to glass vials for liquid scintillation counting. The results are expressed
0 1 0 " 12 1 0 -11 1 0 " 10 1 0 “ 9 1 0 - fl 
A n g i o t e n s i n  II ( mo l / l )
1 0 “7
Fig.3.1
Concentration-dependent effects of A-II on aldosterone synthesis in bovine 
adrenocortical cells which had been in culture for 6 days. Aldosterone response is 
maximal at 3nmol/l A-II and represents a 45 fold increase over basal synthesis. 
Values shown are means ± S.E of 8 replicate incubations.
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as percentages of control uptake. Experimental incubations were carried out in 
octuplicate and results analysed using Student’s t-test.
(iv) Measurements of Intracellular Free Calcium.
ZG cells were prepared as previously described in modified Ham’s F-12 plus 10% 
FCS (see above and Chapter 2). They were seeded into sterile bacterial culture plates 
(Scotlab, Coatbridge, Strathclyde) at a concentration of 5xl06 cells/ml and left at 
37°C, in the presence of 95%C>2, 5%C02, for 72 h (154). Under these conditions the 
cells, which were only loosely attached to the plate, were removed with gentle 
scraping and agitation into KRBGA. The Ca2+-sensitive dye, Fura-2 (Sigma 
Chemical Company, Poole, Dorset) dissolved in dimethyl sulphoxide (DMSO), was 
added to the cell suspension to give a concentration of 10pmol/l. The final 
concentration of DMSO in the cell suspension did not exceed 0.2%. The suspension 
was then aliquoted into 1.5ml Micro-centrifuge tubes containing 1ml aliquots of cell 
suspension and these were placed in a 37°C water bath. HDL-2 and HDL-2 (both 
at 0.5mmol/l cholesterol) or control KRBGA were added to the appropriate 
incubations. The cell suspensions were removed from the water bath after a 
minimum 30min. exposure to Fura-2 and a precise 15min. exposure to the HDL 
subfractions. They were spun for 10s. at 2000g in a Microcentaur centrifuge. The 
supernatant was then removed and the cell pellet resuspended in 2ml of KRBGA. 
The resulting resuspension was placed in the heated chamber (37°C) of a Perkin- 
Elmer LS-3B Fluorescence Spectrometer. Fluorescence measurements were carried 
out at a single excitation wavelength of 340nm, recording the fluorescence signal at 
the Fura-2 emission wavelength of 505nm. A-II was added in a volume of 20pi to 
give a final concentration of lO^mol/l. Details of single wavelength excitation and
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emission calibration for Ca2+-chelating dyes are as described by Rink and Pozzan 
(155) using the following equation:
F - F ^ n 
[Cafcl  = _______ • K,
Fmax - F
F,^ is the fluorescence signal when all the Fura-2 is calcium-bound. F ^  is the 
fluorescence signal when all the Fura-2 is in its free form. The above equation 
enables the calculation of any [Ca2+]j denoted by any measured fluorescence, F, 
between F ^  and F ^ . The Kj for Fura-2 has been determined as 224nm at 37°C 
(61).
Individual measurements were replicated as indicated in fig.3.6 Results are given 
as mean ± S.E.M.
33  Results
Acute effects (Ihl of HDL subfractions on basal and A-II stimulated steroid 
synthesis in isolated adrenocortical cells 
HDL-cholesterol stimulated basal aldosterone (Fig.3.2a) and cortisol synthesis 
(Fig.3.2b) in a dose-dependent manner, although a much greater stimulatory effect 
was observed with cells incubated with HDL-2. A-II-stimulated steroid synthesis was 
also enhanced by HDL-cholesterol. The effects of HDL-2 on A-II-stimulated cortisol 
synthesis were greater than those of HDL-3. However, any differences in the action 
of the two subfractions on A-II stimulated aldosterone synthesis are less obvious. 
The effects of HDL-cholesterol (0.2mmol cholesterol/1) on the aldosterone and
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Effects of HDL-cholesterol (0.4mmol/l) on basal accumulation of 45Ca in freshly 
isolated adrenocortical cells which had been pre-treated with lipoprotein/vehicle for 
15min. prior to addition of 45Ca.
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cortisol responses to a range of different A-II concentrations are shown in Figs.3.3a 
and 3.3b. The effects of the two lipoproteins on the aldosterone or cortisol responses 
to A-II are similar. In cells incubated with HDL-cholesterol, an enhancement of the 
aldosterone response to A-II (p<0.01) was observed at lower concentrations of 
hormone (1010 and 10'9mol/l) However, at the higher two concentrations of A-II 
(10^ and 10*7mol/l) this enhancement was not apparent. In contrast, HDL-cholesterol 
significantly increased A-II-stimulated cortisol synthesis at every concentration used
(p<0.01).
Sustained effects f24h") of HDL subfractions on basal and A-II-stimulated steroid 
synthesis in cultured adrenocortical cells 
Pre-treatment of cultured cells for 24h with HDL subfractions prior to a lh acute 
incubation, markedly affected steroidogenesis. Basal aldosterone (Fig.3.4a) and 
cortisol synthesis (Fig.3.4b) were increased by factors of 3 and 12 respectively with 
HDL-2 and by factors of 4.5 and 15 respectively with HDL-3. Without pre-treatment 
with HDL-cholesterol these cells were very sensitive to hormonal stimulation, 
addition of A-II increased aldosterone output 30 fold and cortisol output 42 fold 
when compared with basal synthesis. Pre-treatment with HDL-cholesterol increased 
total A-II-stimulated production of aldosterone and cortisol. However, the stimulatory 
response of the cells to A-II was significantly reduced in the presence of HDL- 
cholestrol because of the enhanced steroid output in the absence of A-II.
Effects of HDL subfractions on basal 45Ca uptake in isolated adrenocortical cells 
Neither HDL-2 nor HDL-3 (both at 0.4mmol cholesterol/1) had any effect on 
acute 45Ca uptake which was measured after 30s. (Fig.3.5). Similarly, HDL-2-treated
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samples still showed no difference from control incubations after 2 min. although 
HDL-3 treated cells had accumulated significantly less radioactivity by this time 
(p<0.01). However, after 30 min., cells treated with either HDL-2 or HDL-3 had 
taken up approximately 15% less radioactivity than vehicle-treated samples.
Effects of HDL subfractions on basal and A-II stimulated intracellular free calcium 
in adrenocortical cells
Fig.3.6 demonstrates the effects of HDL-2 and HDL-3 on basal and A-II 
(lO^mol/l) stimulated free [Ca2+]; in ZG cells plated down for 72 hours prior to 
experiment.
In control samples, A-II increased free [Ca2+]s from 136±5 nmol/1 to 241±18 nmol/1 
(n=5). In samples treated with HDL-2 and HDL-3, basal free [Ca2+]i was 120±18 
(n=2) and 137±13 nmol/1 (n=6) respectively. Addition of A-II increased these values 
to 160±3 for HDL-2 and 216±27 for HDL-3.
3.4 Discussion
The availability of cholesterol to cytochrome P-450^, located in the inner 
mitochondrial membrane of adrenocortical cells, is rate-limiting step in steroid 
biosynthesis. This substrate can be derived from a variety of sources including de 
novo synthesis from acetate, hydrolysis of stored cholesteryl esters and uptake of 
circulating plasma lipoproteins. Cholesterol may originate from different lipoprotein 
sources in different tissues. For instance, serum LDL has been cited as the source 
of cholesterol in bovine adrenal cells (99) whereas HDL is the major source in rat 
cells (105). Studies with newborn rat adrenocortical cells have also suggested that 
HDL may alter the ratio of 21-hydroxylated: 20a-reduced products of progesterone
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in these cells; that is the lipoprotein may be involved not only in substrate supply 
but also in the modulation of steroid pathways away from inactive reduced 
metabolites towards synthesis of active corticosteroids (156). However, recent in vitro 
studies have indicated that HDL may be a more efficient cholesterol donor than 
LDL in short-term incubations of bovine cells (103).
Plasma HDL levels are an important factor in the incidence and prevalence of 
artherosclerosis (157). This is related to the ability of HDL to remove cholesterol 
from cells and to transport it to the liver for breakdown and removal from the body. 
This reverse cholesterol transport is critical for cholesterol homeostasis as most cells 
cannot metabolise cholesterol they accumulate. Steroidogenic cells are a notable 
exception and, in vivo, HDL particles deliver cholesterol to them, as well as to liver 
cells (100). My own data (Figs.3.2a and 3.2b) show significant increases in both 
basal and A-II stimulated steroid synthesis at a range of HDL concentrations, 
confirming that HDL supplies substrate cholesterol for steroidogenesis. These same 
data also suggest that HDL-2 has a greater effect on steroid synthesis (to a lesser 
extent on A-II-stimulated but certainly on basal) than HDL-3. The reason for this 
is unclear. The different ratios of free cholesterol: cholesteryl ester ratio in the two 
subfractions may provide an explanation. HDL-3 is a smaller, denser particle and the 
action of a plasma-borne lecithin cholesteryl-acyl transferase converts free cholesterol 
in these particles to cholesteryl ester and forms larger HDL-2 particles (100). In the 
present experiment the total cholesterol content of HDL-2 and HDL-3 was identical 
but the cholesteryl ester content of HDL-2 was greater than that of HDL-3. If 
cholesteryl ester is more efficiently absorbed or transported into the cell, this would 
account for the greater effect of HDL-2. However, others have suggested that HDL- 
associated free cholesterol, rather than cholesteryl ester, is preferentialy utilised as
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substrate for steroidogenesis (105,106).
My results also demonstrate (Figs.3.3a and 3.3b) a marked difference in 
responsiveness to HDL of aldosterone and cortisol synthesis in isolated cells treated 
with A-II. When compared to controls, production of both steroids is enhanced by 
HDL-2 and HDL-3 at lower concentrations of A-II (1010 and 10'9 mol/1). Both 
lipoproteins also enhance cortisol production at higher concentrations of A-II (lO*8 
and 10-7 mol/1). However, at these same higher A-II concentrations, the aldosterone 
response to HDL-2 and HDL-3 cannot be distinguished statistically from control 
values. Earlier work in this laboratory may provide an explanation for this 
phenomenon. It has been established that unfractionated HDL inhibits vasopressin- 
stimulated platelet aggregation by reducing [Ca2+]j (Simpson and Graham, 
unpublished data). Treatment with HDL-2 also reduces 43Ca accumulation by platelets 
(D. Graham, unpublished data). Others have confirmed that physiological 
concentrations of HDL-2 are anti-aggregatory and that this may be linked with the 
occupation of cell-surface receptors by HDL-E, a subclass of HDL-2 which is rich 
in apolipoprotein E (158). If, as in platelets, HDL decreases [Ca2+]ln in adrenocortical 
cells, either by a receptor-mediated process or by altering plasma membrane 
cholesterol composition to affect membrane fluidity and perhaps ion-channel activity 
(159,160), this may explain the differing responsiveness of A-II-stimulated 
aldosterone synthesis and cortisol synthesis to HDL. Aldosterone synthesis, more so 
than cortisol synthesis, is sensitive to variations in [Ca2+]j (see chapter 2).
HDL-2 and HDL-3 had little or no effect on 45Ca uptake in glomerulosa cells 
measured after 30s and 2 min. It has been demonstrated previously that agonist- 
sensitive 45Ca uptake is linear during this period (79,158). Significant inhibition of 
45Ca accumulation by both subfractions was only measurable after 30min, at a time
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when steady-state conditions have been achieved (rate of 45Ca uptake has reached a 
plateau) and 45Ca content, under these conditions, reflects total intracellular calcium 
(including Ca2* stored in the endoplasmic reticulum and the mitochondrion) rather 
than [Ca2+]j. Taken together these data would argue against any cytoplasmic receptor- 
associated effect of HDL on the uptake of [Ca2+]0. More importantly, HDL 
subfractions appeared to have no significant effect on the concentration of basal and 
A-II-stimulated (lO^molA) free [Ca2+]j. (Fig.3.6). However, HDL-2 replication 
I was too small (n=2) to draw meaningful conclusions.
Ignoring possible calcium-related effects, the apparent disparity between A-II- 
stimulated aldosterone and cortisol synthesis in isolated cells incubated with HDL- 
cholesterol, may simply demonstrate that zona fasiculata/reticularis cells utilise HDL- 
cholesterol more readily than zona glomerulosa cells. For aldosterone synthesis in 
the rat, endogenously-synthesised cholesterol appears to be more important than 
cholesterol derived from exogenous lipoproteins whereas in zona fasiculata/reticularis 
cells the opposite seems to be the case (104). If a similar preference pertains in 
bovine cells, it would provide an alternative explanation for my observations.
The actions of HDL-cholesterol on adrenocortical cells are not confined to acute 
effects (3h) on steroid output. HDL-cholesterol can also provide substrate for 
adrenocortical steroidogenesis in longer term incubations (Figs.3.4a and 3.4b). Pre­
incubating cultured glomerulosa cells for 24h with HDL-cholesterol had a marked 
effect on steroid output, increasing aldosterone and cortisol synthesis by around 4 
and 13 fold respectively. These increases in steroid output were much greater than 
those obtained in isolated cells (see above) and can be explained by the much lower 
levels of basal steroid synthesis observed in cultured cells. Although pre-incubation 
with HDL-cholesterol also increased total A-II-stimulated aldosterone and cortisol
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output, the net response of both steroids to A-II (lO^mol/l) was diminished. The 
differences in responsiveness to A-II probably relates more to changes in 
unstimulated output than net synthesis in stimulated cells. For example, maximal 
stimulated output in cultured cells is similar to that in cells which have been freshly 
isolated. However, unstimulated cultured cells produce less aldosterone than freshly 
isolated cells and hence the maximum degree of stimulation to A-II is much greater.
In summary, this study confirms that HDL-2 and 3 in vitro are readily usable 
sources of cholesterol for both basal and, to a lesser degree, A-II-stimulated 
steroidogenesis. Further studies with ion sensitive fluorescent dyes may answer the 
question as to whether lipoproteins additionally affect adrenocortical calcium 
metabolism. The selective use of inhibitors of de novo cholesterol synthesis, in 
conjunction with lipoproteins, may help to identify any inter-zonal variations in the 
source of cholesterol for steroidogenesis within the bovine adrenal cortex.
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BENZODIAZEPINES AND STEROID SYNTHESIS.
Benzodiazepines, in addition to their sedative, hypnotic and tranquilizing actions, 
can exhibit both positive and negative effects on steroidogenesis. The next two 
chapters of this thesis will look at both phenomena in detail. Chapter 4 will focus 
on the inhibitory effects of two of these drugs, midazolam and diazepam, on steroid 
synthesis. The next section will then examine the proposed stimulatory effects of 
several benzodiazepines on adrenocortical cholesterol transport in whole cells by 
measuring aldosterone synthesis under both basal conditions and in the presence of 
HDL subfractions to act as cholesterol donors.
CHAPTER 4.
INHIBITORY EFFECTS OF BENZODIAZEPINES ON STEROID SYNTHESIS.
4.1 Introduction
Benzodiazepines can inhibit adrenocortical steroidogenesis (162,163). Two different 
mechanisms have been suggested to explain this inhibition: (i) direct competition 
with substrates for steroid-hydroxylating enzymes and (ii) a receptor-mediated 
process involving cellular calcium metabolism.
Evidence that benzodiazepines inhibit steroidogenic enzymes comes from studies 
examining cortisol synthesis in isolated bovine adrenocortical cells (138). It was 
noted that inhibition of ACTH-stimulated synthesis was associated with increased 
pregnenolone and 17a-hydroxyprogesterone (17-OHP) production. Also, added 17- 
OHP, pregnenolone and progesterone were converted to cortisol less efficiently in 
cells treated with benzodiazepine drugs. From these data, it was concluded that, like 
many other drugs with an imidazole moiety (164,165), benzodiazepines inhibit
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adrenal cytochrome P450 enzymes. However, unlike imidazole drugs such as 
etomidate, ketoconazole and omeprazole (166,167,168), benzodiazepines inhibited 
microsomal enzymes more strongly than those in mitochondria. Diazepam appeared 
to be a particularly effective inhibitor of 17a-hydroxylase activity. Since the 
potencies of benzodiazepines and imidazoles for adrenocortical cytochrome P450 
enzymes are related to the affinities that the hepatic cytochrome P450 oxidase 
enzymes show for these drugs, it seems unlikely that interference with microsomal 
steroid hydroxylations is receptor-mediated.
Inhibition of aldosterone synthesis in rat adrenocortical cells (162,163) cannot be 
explained by reduced microsomal 17a-hydroxylase activity since aldosterone 
synthesis does not involve this step nor does rat adrenal contain 17a^ hydroxylase. 
Also, the concentration of diazepam needed to inhibit microsomal hydroxylation 
reactions is much greater than that required to inhibit aldosterone synthesis. A more 
likely explanation of the effects of diazepam on aldosterone synthesis is that they 
are receptor-mediated. Benzodiazepine receptors have been identified in the adrenal 
cortex (118,169) and it is significant that the dissociation constant (Kd) value for 
diazepam binding is appropriate for the effects of diazepam on aldosterone synthesis 
(162). If, as in the heart, binding of benzodiazepines to adrenocortical receptors 
closes membrane calcium channels (128), diazepam would tend to oppose the actions 
of angiotensin II, which stimulates calcium uptake (82,141,170).
In this chapter the inhibitory action of midazolam on steroidogenesis in bovine 
adrenocortical cells in vitro has been examined more closely. Midazolam has a fused 
imidazole ring in addition to the more basic benzodiazepine structure exhibited by 
drugs such as diazepam. One might expect this drug to inhibit aldosterone synthesis 
by interfering with P-450 enzyme function since previous studies have indicated that
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midazolam inhibits 21 hydroxylation as well as 17-a hydroxylation.
First, I compared the concentration-dependent effects of midazolam on 
adrenocorticophic hormone (ACTH)-stimulated cortisol synthesis with those on 
potassium-stimulated aldosterone synthesis. Since the mechanism of ACTH action 
is widely considered to be less dependent on calcium than that of potassium, a 
difference in sensitivity to benzodiazepines was anticipated. Secondly, I measured 
the concentration-dependent effects of midazolam on 21-hydroxylase activity, firstly 
by assaying 17-OHP production in cells incubated with and without ACTH and then 
more directly, by measuring conversion of 21-deoxycortisol to cortisol in zona 
fasiculata/reticularis cells and the conversion of 116-hydroxyprogesterone to 
aldosterone in zona glomerulosa cells. Finally, I investigated possible inhibitory 
effects of both midazolam and diazepam on basal and potassium-stimulated uptake 
of extracellular 45Ca, and compared the concentration-dependent effects of midazolam 
on 45Ca uptake in cells isolated from the zona glomerulosa and zona fasiculata 
regions of the gland.
4.2 Materials and Methods,
(i) Isolation of Adrenocortical Cells
Cell suspensions enriched with aldosterone-synthesising zona glomerulosa cells 
were prepared as described in Chapter 2 except that Ham’s F-12, containing 
2.5mmol/l Ca2+, and 0.2% BSA, was substituted for medium 199 during cell 
preparation and in all experimental incubations.
Cell suspensions containing high proportions of cortisol-synthesising zona 
fasiculata/reticularis cells were prepared in Ham’s F-12, again as described in chapter 
2 but in this case isolating cells from the Percoll gradient with specific gravity
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>1.052-<1.097.
(ii) Steroid Incubations
All incubations were carried out in sextuplicate for lh at 37°C in an atmosphere 
of 95% 0& 5% C 02 in a total volume of 0.5ml, containing approximately 2xl05 
cells. Incubations were carried out in Ham’s F12 medium containing 0.2% BSA and 
2.5mmol/l Ca2+. The concentration-dependent effects of midazolam (Roche Products, 
Welwyn Garden City, Herts, U.K.) on basal and ACTH (Synacthen; Ciba, Horsham, 
Sussex)-stimulated cortisol and 17-OHP synthesis were examined. In addition, the 
direct effects of the drug on 21-hydroxylase activity were investigated in zona 
fasiculata/reticularis cells using 21-deoxycortisol and in zona glomerulosa cells using 
116-hydroxyprogesterone (both from Sigma Chemical Company, Poole, Dorset, U.K.) 
as substrates. To examine the effects of midazolam and diazepam (Phoenix 
Pharmaceuticals, Gloucester, Gloucs. U.K.) on basal and potassium-stimulated 
aldosterone synthesis, zona glomerulosa cells were incubated in Krebs’ bicarbonate 
Ringer (KRBGA), containing calcium at 2.5mmol/l plus glucose and BSA at 0.2%, 
modified to give final potassium concentrations of 3.8 and 10mmol/l. All reactions 
were stopped by the addition of 0.25ml methanol and then centrifuged at 800g for 
10 min before removal of supernatants which were stored at -20°C for steroid 
analysis.
Measurement of cortisol and aldosterone synthesis were carried out by 
radioimmunoassay as described in Chapter 2. 17-OHP production was kindly 
measured by Dr C.E. Gray, Dept, of Clinical Biochemistry, Royal Infirmary, 
Glasgow, again by direct radioimmunoassay. Results were expressed as nmol 
steroid/106 cells per h and were analysed using Student’s t-test.
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(iii) 45Ca Uptake Studies 
45Ca uptake was measured according to the method described in Chapter 3. Cells 
were stimulated with K+ (final concentration 10.8mmol/l) at the time when 45Ca was 
added. To maintain uniform osmolarity, the potassium content of KRBGA was 
adjusted by substituting KC1 for NaCl. The results are expressed as percentages of 
control uptake. For each experimental run, cells with all different treatments were 
incubated simultaneously. Experimental runs were then replicated five times and the 
results were analysed using Student’s paired t-test.
4,3 Results.
Effects of midazolam on cortisol synthesis in isolated adrenocortical cells 
Figure 4.1a shows the concentration-dependent inhibition of basal and ACTH- 
stimulated cortisol synthesis by midazolam. The thresholds for inhibition of basal and 
ACTH-stimulated cortisol synthesis were 3.4 and 13.6pmol/l respectively (pcO.OOl). 
Figure 4.1b shows concurrent changes in 17-OHP synthesis. There was an increase 
in basal and stimulated 17 OHP synthesis, rising to maxima with 13.6 and 6.8pmol 
midazolam/1 respectively (p<0.001). At these concentrations, midazolam presumably 
inhibits 21-hydroxylase activity in a dose-dependent manner. The subsequent decline 
in 17-OHP synthesis which occurs over the same concentration range as that for the 
inhibition of ACTH-stimulated cortisol synthesis (Fig.4.1a) could be explained by an 
additional effect of midazolam on 17a hydroxylation at higher concentrations.
Figure 4.2a further illustrates the effects of midazolam on microsomal 
hydroxylation when 21-deoxycortisol is provided as substrate for 21-hydroxylation. 
Although 21-deoxycortisol is not a normal substrate, it can be 21-hydroxylated to 
form cortisol. Three concentrations of 21-deoxycortisol were used (1, 10 and
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Fig-4-3
Concentration-dependent effects of midazolam on aldosterone synthesis from added 
116-hydroxyprogesterone (2.5pmol/l) in isolated bovine zona glomerulosa cells. 
Values shown are means ± S.E. (n=6).
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1 0 0 pmol/l); in each case, cortisol synthesis was inhibited in a dose-dependent 
manner by midazolam. At the lower drug concentrations (1  and 10pmol/l), the 
inhibitory thresholds for midazolam were 2.8 and 0.7pmol/l respectively (p<0.05). 
The inhibitory constant (K,) was 35pmol/l (Fig.4.2b) which corresponds with the 
50% inhibitory dose (IQo) of 22pmol/l for the effects of midazolam on ACTH- 
stimulated cortisol synthesis (Fig.4.1a).
Effects of midazolam and diazepam on aldosterone synthesis in isolated 
adrenocortical cells
Figure 4.3 shows the effects of midazolam in zona glomerulosa cells on 
aldosterone synthesis from added 116-hydroxy progesterone (2.5pmol/l). The drug 
inhibited synthesis in a dose-dependent manner with an inhibitory threshold of 
1.9pmol/l and a K, of 54pmol/L
The effects of both midazolam and diazepam on basal and potassium-stimulated 
(3.8 and 10mmol/l K+ respectively) aldosterone synthesis are shown in Fig.4.4. 
Midazolam significantly inhibited basal synthesis at each concentration used (p<0.05), 
but no such effect was observed for diazepam. Both drugs markedly inhibited 
potassium-stimulated aldosterone synthesis at 0.85pmol/l. For diazepam, this was 
partial and was maximal at this concentration. However, the effects of midazolam 
were more obviously concentration-dependent, and were greater than those of 
diazepam at higher concentrations. Note that the inhibitory effects of benzodiazepines 
on potassium-stimulated aldosterone synthesis occurred at lower concentrations (IC50 
1.2pm ol/l for midazolam and 0.8pmol/l for diazepam) than those required to inhibit 
ACTH-stimulated cortisol synthesis (Fig.4.1a), conversion of 21-deoxycortisol to 
cortisol (Fig.4.2a) or conversion of 116- hydroxyprogesterone to aldosterone
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(Fig.4.3), which have IC^ values for midazolam of 22, 29 and 10pmol/l respectively.
Effects of midazolam and diazepam on 4SCa uptake in isolated adrenocortical cells 
In preliminary experiments, we confirmed the findings of several other groups 
(79,158) that the rate of 45Ca uptake by adrenocortical cells remained linear during 
the first 2 min of incubation. In the present experiments, uptake was measured over 
60s during this initial 2 min period. Figure 4.5 illustrates the effects of potassium 
stimulation on 45Ca uptake by zona glomerulosa cells in the presence and absence 
of midazolam. As expected, potassium (10.8mmol/l) stimulated 45Ca uptake, probably 
by opening voltage-sensitive calcium channels. Treatment with midazolam 
significantly inhibited both basal (p<0.01) and potassium-stimulated uptake (p<0.05). 
However, comparing basal plus midazolam data with potassium-stimulated plus 
midazolam data indicates that the effects of potassium on calcium uptake are not 
completely abolished by the drug at this concentration.
The effects of increasing concentrations of midazolam on initial rates of basal 45Ca 
uptake are illustrated in Fig.4.6a and 4.6b. Figure 4.6a shows data from a 
preparation containing mainly zona glomerulosa cells; figure 4.6b displays effects on 
zona fasiculata/reticularis cells. In both cases, midazolam inhibited uptake in 
unstimulated cells, although the effect on zona fasiculata/reticularis cells only 
achieved statistical significance at 13.6 and 55nmol drug/1. The zona glomerulosa 
cells appeared to be more sensitive to midazolam; all concentrations of the drug 
tested significantly reduced the rate of 45Ca uptake relative to controls.
4.4 Discussion.
Adrenal and hepatic cytochrome P450 enzymes are inhibited by many drugs. In
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particular, imidazole derivatives such as etomidate and ketoconazole interfere strongly 
with these enzymes (165,167). Since the benzodiazepine, diazepam, is a well known 
inhibitor of hepatic cytochrome P450 enzymes, we tested its adrenocortical effects 
and found that steroidogenesis was inhibited. Interestingly, midazolam, a 
benzodiazepine which also contains a fused imidazole ring, proved to be a more 
potent inhibitor of microsomal steroid hydroxylase activity and hence of ACTH- 
stimulated cortisol synthesis (138). The present study has confirmed and extended 
these findings.
Midazolam significantly inhibited 21-hydroxylase activity in basal and ACTH- 
stimulated zona fasiculata/reticularis cells causing 17-OHP to accumulate. The 
specific effects of midazolam on 21-hydroxylase activity was assessed by measuring 
cortisol production from added 21-deoxycortisol in zona fasiculata/reticularis cells 
and by measuring aldosterone synthesis from added 116-hydroxy progesterone in zona 
glomerulosa cells. Inhibition of both aldosterone and cortisol synthesis was 
competitive, with Ki values of 35 and 54 jxmol midazolam/1 respectively. However, 
the effects of midazolam on 17-OHP synthesis were biphasic, with a decrease 
observed at higher drug concentrations. This higher concentration effect corresponded 
to an observed decrease in stimulated cortisol synthesis (Figs.4.1a and 4.1b) and 
probably reflects an inhibition of 17a-hydroxylation in addition to 21 hydroxylation. 
In contrast, diazepam appears to be a more potent inhibitor of 17a- than 21- 
hydroxylase (138).
Two other groups have described inhibitory effects of diazepam on 
corticosteroidogenesis (162,163). In both of these studies, aldosterone production by 
rat adrenocortical cells was used as an end-point and both found inhibitory effects 
using drug concentrations a magnitude lower than in previous studies carried out in
106
this laboratory (138). Given that aldosterone synthesis does not involve 17a- 
hydroxylation and that, at nanomolar concentrations, diazepam would not be expected 
to affect 21-hydroxylation directly, the nature of this additional inhibition requires 
further explanation. One possibility may be that rat cells are more sensitive to 
benzodiazepines than bovine cells. Alternatively, these drugs, when acting on zona 
glomerulosa cells, could interfere with some aspect of adrenocortical control which 
is unique to the synthesis of aldosterone. In support of this hypothesis, previous 
work has reported an inhibition of the conversion of corticosterone to aldosterone 
by diazepam, although again this was observed at high drug concentrations (138). 
To investigate this further, I examined the effects of midazolam and diazepam on 
K+-stimulated bovine adrenal cells. The results indicate that benzodiazepine inhibition 
of stimulated aldosterone synthesis in bovine cells is at least as sensitive as 
previously reported for rat cells and is 10-20 times more sensitive than the inhibition 
of ACTH-stimulated cortisol synthesis, the conversion of 21-deoxycortisol to cortisol 
or the conversion of 116-hydroxyprogesterone to aldosterone.
Control of zona glomerulosa cells differs from that of zona fasciculata cells. 
Whereas cortisol synthesis is controlled by ACTH at a single early step only, i.e. 
the conversion of cholesterol to pregnenolone, aldosterone synthesis is regulated 
additionally at later points in its biosynthetic pathway when corticosterone is 
converted to aldosterone (171). Control of aldosterone synthesis is exerted by several 
agonists which do not stimulate cortisol synthesis. For example, only small increases 
in extracellular [K+] are required to stimulate steroidogenesis (172). The stimulatory 
effects of K+ at both early and late steps in the biosynthetic pathway of aldosterone 
are known to be mediated by increased calcium uptake through voltage-sensitive 
calcium channels following depolarization of the membrane (173,174). These calcium
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channels are very sensitive to small negative potentials and show rapid inactivation, 
resembling T-type channels found in neurones and atrial pacemaker tissues. They 
also display high sensitivity to drugs such as nitrendipine and nifedipine. Both K+- 
stimulated aldosterone synthesis and calcium uptake have been shown to be inhibited 
by voltage-sensitive calcium channel blockers (82,175). Since benzodiazepines have 
been shown to inhibit depolarisation-induced calcium uptake in several tissues 
(176,177,178) we tested whether midazolam interfered with signal-response coupling 
in adrenocortical cells in a way similar to calcium channel antagonists.
Midazolam reduced 45Ca uptake in K+-stimulated cells to the level of that in 
unstimulated cells. This effect is similar to that observed by others with 
dihydropyridine antagonists (82,175). Notice, however, that midazolam also reduced 
uptake in unstimulated cells and that, unlike cells treated with nifedipine or 
nitrendipine, the difference between basal and K+-stimulated uptake in the presence 
of midazolam was still statistically significant. So, although midazolam inhibits K+- 
stimulated calcium uptake, it does not abolish the effect completely at this 
concentration.
It is relevant that the relationship between the concentration of midazolam and 
inhibition of 45Ca uptake by zona glomerulosa cells is similar to that for midazolam 
and K+-stimulated aldosterone synthesis. The fact that aldosterone synthesis, more 
than that of cortisol, is dependent upon changes in cytosolic free Ca2+, may explain 
why higher concentrations of benzodiazepine are needed to inhibit ACTH-stimulated 
cortisol synthesis. In line with this argument, the inhibition of calcium uptake by 
zona fasciculata cells by midazolam appears to be weaker than that in zona 
glomerulosa cells.
The nature of the low-dose anti-steroidogenic effects of benzodiazepines suggests
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a mechanism other than non-specific interference with adrenal cytochrome P450 
enzymes. One possibility is that the mechanism is receptor-mediated. Receptors have 
been characterized in the central nervous system through which benzodiazepines can 
positively or negatively modulate the effects of the inhibitory neurotransmitter 
aminobutyric acid (GABA), on neuronal firing (115,179). A different receptor has 
been identified in peripheral tissues. These latter receptors are present in large 
numbers in the adrenal cortex, and have been localized to the outer mitochondrial 
membrane (119). Moreover, natural ligands for these receptors, proteins known as 
endozepines, have recently been identified (123). The functions of these receptors 
would seem to be incompatible with any effects mediated by benzodiazepines on 
calcium metabolism, as their cellular location would rule out a primary influence on 
plasma membrane calcium transport. They have also been most often linked with 
increased rather than decreased steroidogenesis (see Chapter 5); endozepines and 
diazepam have both been shown to increase pregnenolone synthesis in mitochondria 
from a variety of tissues (123,180) possibly by facilitating cholesterol transport to 
the inner mitochondrial membrane (181). However, since inhibitory effects of 
benzodiazepines have also been reported (182), this mechanism cannot be completely 
discounted at present. In addition, although adrenal studies have demonstrated that 
the peripheral receptor is primarily associated with the mitochondrion, the possibility 
that it is also associated with membranes from other organelles, including the plasma 
membrane cannot be excluded (119).
In summary, I have demonstrated a direct inhibitory effect by midazolam on 
steroid hydroxylase reactions in vitro. Microsomal 21-hydroxylation is particularly 
sensitive to this drug; higher concentrations appear to inhibit 17a hydroxylations. 
This competitive inhibition explains why ACTH-stimulated cortisol synthesis is
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inhibited, but does not account for the higher sensitivity of K+-stimulated aldosterone 
synthesis to benzodiazepines. The involvement of the peripheral receptor in 
mediating this effect is unlikely, due to it subcellular localization. The additional 
inhibitory effects of midazolam on aldosterone synthesis are more likely to be due 
to a blocking of calcium uptake through one or more types of plasma membrane 
channel (51). The interrelationships between the actions of endozepines and cation 
transport in the adrenal cortex merit further investigation.
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CHAPTER 5.
STIMULATORY EFFECTS OF BENZODIAZEPINES ON STEROID SYNTHESIS.
5.1 Introduction.
Binding sites for benzodiazepines have been identified both within the central 
nervous system (CNS) and outside in perpiheral tissues (116,119). These central 
binding sites are associated with the GABA-gated chloride ion channel and drugs 
binding at these sites modulate the effects of GABA (the principal inhibitory 
neurotransmitter in the CNS) on ion channel activity and hence on membrane 
potential and neuronal firing (115,117). Centrally-acting benzodiazepines are used 
therapeutically as I tranquillisers and sedatives.
Peripheral benzodiazepine binding sites have been identified and localised using 
4-chlorodiazepam (R05-4864) which has no known therapeutic effects (118). 
Peripheral sites are found in many tissues but are present at greatest density in 
steroidogenic tissues, particularly the adrenal cortex (118). Further investigation in 
adrenocortical cells has localised the peripheral binding site to the outer 
mitochondrial membrane (119) and it is most often refered to as the mitochondrial 
benzodiazepine receptor (MBR). The MBR is pharmacolgically distinct from the 
benzodiazepine receptors in the CNS. Clinically potent benzodiazepines, such as 
clonazepam bind with high affinity to central receptors but have negligible potency 
for the MBR while the reverse is true for peripheral ligands such as R05-4864 and 
PK11195 (116,183). Furthermore, in contrast to central receptors, binding of 
benzodiazepines to the MBR is not affected by GABA or chloride ions (118).
MBR ligands induce a wide range of effects on cell function including alterations 
in proliferation and proto-oncogene expression (121). However, it has also been
I l l
reported that steroid biosynthesis is stimulated in whole cells and mitochondria by 
a number of these MBR selective drugs (114,122,123). This has led to speculation 
that benzodiazepines, selective for the MBR, mimic the effects of the endogenous 
cycloheximide-sensitive "labile" protein proposed to regulate translocation of 
cholesterol from the outer to the inner mitochondrial membrane (181). This is one 
of the most important but, as of yet, least understood, steps in steroid synthesis. It 
is now generally agreed that the major rate-limiting step in steroidogenesis is not P- 
450^ but rather the incorporation of cholesterol into the mitochondrion and its 
subsequent transport from the outer mitochondrial membrane to P-450^, located in 
the inner (95,107). To date MBR ligands have been demonstrated to stimulate 
cortisol and corticosterone synthesis in bovine and rat fasiculata/reticularis cells 
respectively (122). In addition, they also stimulate steroid synthesis in mouse Y-l 
adrenocortical and MA-10 Ley dig cell lines (122,182). However, no-one has, as yet, 
examined the effects of these ligands on the synthesis of aldosterone by glomerulosa 
cells.
Bearing in mind probable difficulties in distinguishing stimulation from the 
inhibition described in Chapter 4, the possible stimulatory effects of benzodiazepines 
on aldosterone production in cultured zona glomerulosa cells were examined in the 
following series of experiments:
(i) Time and concentration-dependent effects of diazepam on basal synthesis.
(ii) Effects of benzodiazepines on synthesis stimulated by the addition of A-II, 
ACTH or K+.
(iii) Effects of benzodiazepines and the high affinity MBR ligand PK11195, on 
steroidogenesis from cholesterol obtained from HDL subfractions.
(iv) In addition to the transport of cholesterol to the inner mitochondrial membrane,
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control of aldosterone synthesis also depends on the rate of deoxycorticosterone 
(DOC) conversion to aldosterone. Since this step also involves transport of precursor 
into the mitochondrion, I decided to investigate whether benzodiazepines stimulate 
aldosterone synthesis from added DOC.
5.2 Materials and Methods.
(i) Cultured adrenocortical Cells 
Cell suspensions rich in aldosterone-synthesising zona glomerulosa cells were 
prepared in modified Ham’s F-12 medium +10% fetal calf serum (FCS) as described 
in Chapters 2 and 3. They were then seeded into 96 well plates (Linbro tissue 
culture plates, Flow Laboratories, Irvine, Strathclyde) at a density of 2xl04 cells/well 
and maintained in culture for 6 days. On day 6, the modified culture medium was 
removed and the cells were washed x3 with unmodified Ham’s F-12 containing 
2.5mmol Ca2+/1 and 2mg/ml BSA. Steroid production was measured over a 3h 
incubation period at 95% 0 2 and 5% COz in a final volume of 200^1 of the same 
medium.
Experiments were set-up as follows:
(a) Time and concentration-dependent effects of diazepam on basal aldosterone 
synthesis: Cells were treated with various concentrations of diazepam in one of three 
ways (i) 24h prior to but not during the subsequent 3h experimental incubation when 
samples were collected for steroid measurement (ii) A 3h incubation with no pre­
incubation (c) For 24h prior to and during a 3h incubation period.
(b) Effects of benzodiazepines on hormone and K+-stimulated aldosterone synthesis: 
Cells stimulated by the addition of 0.1nmol/l ACTH (Synacthen, Ciba Laboratories, 
Horsham, Sussex), lnmol/1 A-II (Sigma Chemical Company, Poole, Dorset) or
113
32mmol/l K+ were treated with diazepam and midazolam (10'7mol/l). To maintain 
uniform osmolarity, the potassium content of the Ham’s F-12 was adjusted, 
substituting KC1 for NaCl, by mixing appropriate volumes of Ham’s F-12 and a high 
K+ KRBGA. Controls were incubated with Ham’s F-12 mixed with normal K+ 
KRBGA.
(c) Effects of benzodiazepines and PK11195 on HDL-stimulated aldosterone 
synthesis: Diazepam, R05-4864 and PK11195, at various concentrations, were added 
either alone, or in combination, to cells together with HDL-2 or HDL-3.
(d) Effects of benzodiazepines on DOC-stimulated late pathway activity: Diazepam, 
R05-4864 and PK11195 were added at a range of concentrations, either on their 
own or in combination, to cells stimulated by the addition of DOC dissolved in 
methanol. The final methanol concentration of the incubations did not exceed 0.2%.
(ii) Extraction and Partial Chromatographic Separation of cell incubation medium.
Although the cross-reactivity of the aldosterone antiserum with DOC is slight 
(0.04%), the medium of cells which had been treated with DOC had concentrations 
(1 or 5|imol/l) which significantly interfered with measurements of aldosterone. To 
remove this exogenous DOC, all samples were subjected to solid-phase 
chromatography prior to aldosterone assay. C-18 Sep-paks (Millipore, Watford, 
Herts.) were primed by addition of 2ml methanol and then washed with 5ml H20 . 
The samples were added to the columns. The columns were again washed with 5ml 
of H20 . Finally, 3ml of 55% methanol were added and this elutant collected. 
Previous studies, using 3H DOC and 3H aldosterone, had determined recovery values 
of 85% and 6% for aldosterone and DOC respectively under these conditions. 
Aldosterone was measured by direct radioimmunoassay as described in Chapter 2
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with no corrections for recovery loss. All incubations were replicated as indicated 
and the data analysed using Student’s t-test.
53 Results.
Time and concentration-dependent effects of benzodiazepines on basal aldosterone 
synthesis in cultured adrenocortical cells 
An acute 3h exposure to diazepam (Fig.5.1) significantly increased basal 
aldosterone synthesis (p<0.01) by between 2 and 4 fold at all concentrations tested 
(109-10'5 mol/1). This increase was not dose-dependent and was not enhanced by an 
additional 24h pre-exposure to the drug. A 24h pre-exposure alone demonstrated an 
aldosterone response of glomerulosa cells to diazepam which persisted in the absence 
of drug.
Effects of benzodiazepines on A-II. ACTH and K*-stimulated aldosterone synthesis 
in cultured adrenocortical cells 
The dose-dependent effects of diazepam on aldosterone synthesis stimulated by a 
range of A-II concentrations is shown in Fig.5.2. Enhancement of stimulated 
synthesis by the drug was most marked (p<0.05; pcO.OOl) at the lower two 
concentrations of A-II used (1010 and 10'9mol/l). This enhancement was only 
observed at concentrations of diazepam <0.1mmol/l and concentrations of drug 
greater than this inhibited stimulated aldosterone synthesis at every concentration of 
A-II tested (p<0.05; p<0.001). There was also little or no enhancement by diazepam, 
at any concentration, when supra-maximal concentrations of A-II (lO^mol/l) were 
used to stimulate steroid synthesis.
Fig.5.3 demonstrates the effects of diazepam and midazolam (10'7mol/l) on the
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Fig.5.1
Concentration-dependent effects of (i) a 24h pre-exposure to diazepam or (ii) a 3h 
acute treatment with the drug or (iii) both of the above, on basal aldosterone 
synthesis in cultured zona glomerulosa cells.
Values shown are means ± S.E. (n=8). Aldosterone synthesis by all diazepam 
treated samples was statistically greater than control (pcO.Ol; Student’s unpaired t- 
test).
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Fig.5.3
Effects of midazolam and diazepam (both at lpmol/1) on A-II (lnmol/1), ACTH
(O.lnmol/1) and K+ (32mmol K+/l)-stimulated aldosterone synthesis in cultured bovine 
zona glomerulosa cells.
Values shown are means ± S.E. (n=8). * indicates significant differences compared 
with controls (p<0.05) using Student’s unpaired t-test.
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three principal physiological stimuli of aldosterone secretion; A-II, ACTH and K+. 
Diazepam, but not midazolam, significantly enhanced both A-II and ACTH- 
stimulated aldosterone synthesis by factors of 1.6 and 1.7 respectively (p<0.01). Both 
drugs significantly decreased K+-stimulated synthesis by a factor of 1.4 (p<0.01).
Effects of benzodiazepines on conversion of HDL-cholesterol to aldosterone in 
cultured adrenocortical cells
The effects of diazepam (10'9mol/l) on the aldosterone dose-response to HDL-2 are 
shown in Fig.5.4. The drug had significant stimulatory effects at all concentrations 
of lipoprotein used (p<0.05, p<0.01, pcO.OOl) with one exception (0.2mmol/l 
cholesterol). The most marked stimulatory effect of diazepam was at the highest 
concentration of HDL-2 used (0.8mmol/l cholesterol), representing a 1.75 fold 
increase when compared to the appropriate control (pcO.OOl).
At low concentrations of HDL-3 cholesterol (0.05-0.2mmol/l) diazepam (10‘9mol/l) 
had little or no effect on aldosterone synthesis (Fig.5.5) and a significant 
enhancement (p<0.01) was only achieved at the two highest concentrations of HDL- 
3 used (0.4 and 0.8mmol/l). This should be noted and contrasted with the very 
marked stimulatory effect of diazepam on basal synthesis (p<0.001).
The dose-dependent effects of R05-4864 and PK11195 on aldosterone synthesis 
from added HDL-2 cholesterol (0.6mmol/l) are shown in Fig. 5.6. In the presence 
of HDL-2, R05-4864 significantly enhanced aldosterone synthesis at all 
concentrations used (p<0.05; p<0.001). This effect was maximal at lnmol/1 R05- 
4864. PK11195 also enhanced synthesis by 1.5 and 2.7 fold at concentrations of 
10*9 and 10'7 mol/1 respectively (pcO.OOl; p<0.01). When both R05-4864 and 
PK11195 were added together at 10'9 mol/1, the effect on aldosterone synthesis was
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similar to that observed when each drug was added individually. With both drugs 
present at 10*7mol/l, aldosterone synthesis resembled the individual actions of R05- 
4864 and was very much less than that elicited by PK11195 alone. At 104mol/l the 
combination of drugs was markedly inhibitory (pcO.OOl).
The aldosterone response to PK11195 and R05-4864 from added HDL-3 
cholesterol was broadly similar to that in cells treated with HDL-2, the major 
difference being the greater steroidogenic output in the presence of HDL-3 (Fig.5.7). 
By itself, PK11195 was a more potent stimulus to aldosterone synthesis than R05- 
4864. Together at 10'9 and 10‘7mol/l, steroid output resembled that of R05-4864 
alone. Again with both drugs present at 104mol/l, aldosterone synthesis was 
inhibited.
PK11195 did not block the effects of diazepam (Fig.5.8). Indeed, at 10'7mol/l the 
stimulatory effects of PK11195 and diazepam appear to be additive and at lO^mol/l 
the inhibitory effects of diazepam are more marked in the presence of PK11195.
Effects of benzodiazepines on synthesis of aldosterone from added DOC in cultured 
adrenocortical cells
The dose-dependent effects of diazepam on the conversion of DOC (5pmol/l) to 
aldosterone are shown in fig.5.9. At concentrations ranging from 10-8 to 10’5mol/l, 
diazepam-treated cells produced 30-55% more aldosterone than vehicle-treated 
controls (pcO.Ol; pc0.05; pcO.OOl). At a concentration of 10^mol/l, DOC conversion 
was inhibited.
At 10‘9 and 10*7mol/l, R05-4864, but not PK11195, also enhanced DOC (lpmol/1)
conversion to aldosterone (pc0.05; pc0.001)(Fig5.10). At 10^mol/l, neither drug had
any effect on aldosterone output. Curiously however, when PK11195 and R05-4864
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were added together, aldosterone synthesis was inhibited at each concentration tested 
(p<0.01; p<0.05; pcO.OOl), particularly at 10^mol/l.
5.4 Discussion.
Benzodiazepines exert their clinical anxiolytic and anti-convulsant effects by 
modulating the actions of iY' aminobutyric acid (GABA). GABA is a major 
neurotransmitter in the central nervous system (CNS) which inhibits neuronal firing 
by regulating chloride ion channel activity (115,117). A different type of 
benzodiazepine binding site has been identified in tissues outside the CNS (119). 
The concentration of these peripheral sites is especially high in the adrenal gland 
and, in particular, the adrenal cortex (118) where high affinity sites have been 
localised to the outer mitochondrial membrane (119). The presence of mitochondrial 
benzodiazepine receptors (MBR’s) in this tissue does not appear to be associated 
with the activity of any constitutive mitochondrial enzymes (120). Hence, it was 
suggested that these receptors may fulfil a more specialised role relating to 
steroidogenesis. Studies in rats demonstrated a radical decrease in the concentration 
of adrenal MBR’s after hypophysectomy (169). The concentration of kidney MBR’s 
in the same rats showed little or no change. These data indicated that in the adrenal, 
MBR expression was under the control of pituitary gland hormones.
Benzodiazepine ligands can stimulate corticosteroid synthesis in bovine and rat 
ZF/R cells (122). This stimulation is not cycloheximide-sensitive and is not mediated 
by direct activation of P-450^. Further studies, carried out in Y-l and MA-10 
tumour cell lines using a number of benzodiazpine ligands with differing affinities 
for the MBR, demonstrated that the potency of these drugs as stimulators of 
steroidogenesis correlates very closely with their affinities for the MBR and not at
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all with their binding to central-type receptors.
My own results demonstrate that diazepam, which binds to both the MBR and the 
central receptor (184), can stimulate basal aldosterone synthesis in bovine ZG cells 
(Fig.5.1) over a wide concentration range (10'9-10‘5mol/l). This stimulation of steroid 
synthesis at nanomolar concentrations corresponds with the binding affinity of the 
MBR for the drug. This is not just an acute effect, as pretreatment with the drug 
is also sufficient to induce an increased steroid response. Indeed steroid output in 
cells pretreated with diazepam was not significantly different from that in cells 
exposed to diazepam before and during the period when aldosterone production was 
measured.
Diazepam potentiated the stimulatory effects of A-II and ACTH (Figs.5.2 and 5.3). 
For A-II, this enhancement was more effective at lower, sub-maximal concentrations 
of peptide (Fig.5.2). This might indicate that the stimulatory effects of A-II and 
diazepam on aldosterone synthesis are limited by a common reaction, possibly P- 
450^ activity. Below this limit benzodiazepine and A-II effects are additive. Similar 
additive effects were observed with ACTH-stimulated aldosterone synthesis (Fig.5.3). 
Midazolam, of which there are no reports as regards affinity for the MBR, has no 
effect on A-II or ACTH-stimulated synthesis at a concentration of 0.1pmol/l 
(Fig.5.3).
The stimulatory effects of diazepam on cultured cells are in marked contrast to the 
inhibition described in chapter four. There are several possible reasons for this 
discrepancy:
(i) The steroid response of freshly isolated glomerulosa cells to diazepam may be 
different to that of cultured cells. This is unlikely as diazepam inhibited K+- 
stimulated aldosterone synthesis in both freshly isolated and cultured cells (Figs.4.4
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and 5.3).
(ii) The stimulatory effects of diazepam on aldosterone synthesis may be time- 
dependent. The similarity between the acute (3h) and the 24h response to the drug 
demonstrates that this is not the case.
(iii) The effects of diazepam may be concentration-dependent. Drug concentration 
appears to be a critical factor in determining the effects of diazepam on 
steroidogenesis. Diazepam increased basal and stimulated aldosterone synthesis 
(Figs.5.1, 5.2 and 5.3) at concentrations a magnitude lower (nM) than that which 
inhibited synthesis (pM) (Fig.5.2 and (138)). This was not observed with K+- 
stimulated cells where diazepam also inhibited aldosterone synthesis at sub- 
micromolar concentrations (Fig.4.4 and (162)). These data may be explained by 
assuming that diazepam, depending upon its concentration, can affect glomerulosa 
cells in three ways: (a) By inhibiting steroidogenic enzymes (see chapter 4). (b) By 
inhibiting K+-stimulated [Ca2+]0 uptake (see chapter 4) (c) By increasing intra- 
mitochondrial cholesterol transport at the MBR.
Further evidence that the MBR participates in hormone-stimulated synthesis is 
provided by studies using the benzodiazepine, flunitrazepam (182). This weak MBR 
agonist antagonises the steroidogenic effects of ACTH and lutenizing hormone (LH) 
in Y-l and MA-10 cell-lines respectively, suggesting that hormone-stimulated 
synthesis occurs by a mechanism coupled to the MBR.
Although ultimately P-450^ activity is rate-limiting in unstimulated cells, it is the 
rate at which cholesterol is transported to this enzyme in the inner mitochondrial 
membrane which governs availability and hence the rate of steroid synthesis 
(95,107). It is suggested that MBR ligands exert their action by controlling 
cholesterol transport within the mitochondrion (181). Two mechanisms have been
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proposed for intra-mitochondrial cholesterol transport (181), one involving a carrier 
protein in the inter-membrane space and the other a direct transfer of cholesterol 
between membrane compartments at intermembrane contact points.
The involvement of a nascent, cycloheximide-sensitive protein in steroidogenic 
regulation is well-documented (see chapter 1). However, a different 18KDa protein, 
which exhibits the binding properties of the MBR, has been identified, purified and 
sequenced from rat adrenal mitochondria (185). cDNA encoding this protein, when 
expressed in a transformed human kidney cell line, resulted in increased binding of 
MBR ligands (186). This protein has five potential transmembrane spanning 
segments which could allow the receptor to be embedded in both inner and outer 
mitochondrial membranes at contact points which would facilitate cholesterol 
transport. Whatever the mechanism of mitochondrial cholesterol transport, 
benzodiazepines have been demonstrated to stimulate pregnenolone synthesis in 
cholesterol-loaded adrenocortical mitochondria (114,123) and this effect has been 
attributed to an effect on cholesterol transport via the MBR, rather than any direct 
alterations in P-450** activity.
These effects on cholesterol transport prompted the present study of the effects of 
MBR ligands in cultured cells treated with HDL-cholesterol. In addition to diazepam, 
the effects of 4-chlorodiazepam (R05-4864) and an isoquinoline carboxamide, 
PK11195, were also examined. Both have higher affinity for the MBR than 
diazepam (122).
Diazepam, R05-4864 and, in particular, PK11195 all increased the conversion of 
HDL-cholesterol to aldosterone (Figs.5.6, 5.7 and 5.8) with potencies similar to their 
relative abilities to increase basal 20a-progesterone synthesis in Y-l adrenocortical 
cells [ie-PK11195 > R05-4864 > diazepam] (122). When the drugs were present in
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combination their stimulatory effects were not additive, suggesting that all three 
drugs bind to the same receptor. Research done on kidney indicates that the MBR 
has at least two different binding conformations or has separate, mutually exclusive 
binding sites for benzodiazepines and isoquinoline carboxamides (187).
MBR ligands are suggested to exert their effects by mimicing the actions of 
endogenous ligands for this receptor (123). Proteins which inhibit diazepam binding 
to central receptors have been discocvered in a variety of tissues and have been 
termed endozepines or diazepam-binding inhibitors (DBI) (see chapter 1). 
Endozepines stimulated pregnenolone formation in cholesterol-loaded mitochondria 
from mouse Y-l and MA-10 cells (114). DBI and DBI-like peptides are found in 
high concentrations in the adrenal cortex and one such protein, Des-[Gly-Ile]-DBI, 
has been isolated from bovine ZF/R cells (123). Endozepines have been shown to 
stimulate pregnenolone formation by adrenocortical mitochondria in a manner similar 
to diazepam (123), suggesting that both ligands may operate through the same 
receptor, the MBR.
Aldosterone biosynthesis involves the transport of two precursors, cholesterol and 
DOC, to steroidogenic enzymes located in the inner mitochondrial membrane. 
Although little is known about mitochondrial cholesterol transport, even less is 
known about the mechanisms of mitochondrial DOC supply. Diazepam significantly 
increased conversion of DOC to aldosterone (p<0.01) over a concentration range 
(lO'MO^mol/l) which was appropriate for a reaction involving the MBR (Fig.5.9). 
R05-4864 had similar effects, increasing aldosterone synthesis 1.8 fold at a 
concentration of 1.8pmol/l (Fig.5.10). This raises the possibility that the stimulatory 
effects of benzodiazepines on aldosterone synthesis, from added HDL-cholesterol and 
from added DOC, may both be mediated by a similar mechanism involving the
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MBR. If MBR ligands can increase steroid synthesis by activating mitochondrial 
cholesterol translocation (181), then it is tempting to speculate that these drugs may 
act in a similar manner to facilitate mitochondrial DOC transport. There is no direct 
evidence to support this conjecture but a multi-functional role for the MBR has been 
suggested (121). However, not all experimental evidence supports this hypothesis. 
PK11195, the ligand which has highest affinity for MBR (122) and which has the 
most marked effect on aldosterone synthesised from HDL-cholesterol (Fig.5.7), had 
no effect on aldosterone synthesised from added DOC (Fig.5.10). This suggests that 
the positive effects of R05-4864 and diazepam on the conversion of DOC to 
aldosterone cannot be mediated through the MBR and that both drugs increase 
conversion of DOC to aldosterone by some other mechanism.
Recent immunofluorescence studies of adrenocortical cells have indicated that 
benzodiazepine receptors are not associated exclusively with the mitochondrion. 
Peripheral binding sites have been identified in plasma membranes of both 
glomerulosa and fasiculata/reticularis cells (188). Similarly, peripheral type plasma 
membrane receptors have been identified in heart and in synaptosomes (176,177). 
These have been linked to calcium channel function. In guinea-pig myocytes , both 
R05-4864 and diazepam inhibited the depolarisation induced uptake of Ca2+ 
(128,189). As PK11195 blocked the effects of these benzodiazepines, the idea that 
PK11195 is an antagonist of the peripheral benzodiazepine receptor has become 
established. In adrenocortical cells, this study and others have noted that [Ca2+]0 
uptake is inhibited by midazolam, diazepam and other benzodiazepines (190). 
Assuming that PK11195 is an antagonist of diazepam-inhibited [Ca2+]c uptake, this 
plasma membrane effect may explain the differences between the steroidogenic 
effects of R05-4864 and PK11195.
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Although it is generally accepted that elevated [Ca]; increases the activities of 
both the early and late pathways of aldosterone synthesis (145), there is also 
evidence to suggest that Ca2+ is not an absolute requirement for late pathway 
activity. For example, purified 116-hydroxylase can catalyse formation of aldosterone 
from DOC in the absence of added Ca2+ (19). Recently, it has been reported that a 
Ca2+ concentration of 2.5pmol/l inhibited the conversion of DOC to aldosterone by 
isolated adrenocortical mitochondria (191). Using adrenocortical mitochondria 
prepared as per chapter 2, I too have observed similar effects at much higher Ca2+ 
concentrations. Addition of Ca2+ in the presence of lpmol/1 corticosterone reduced 
aldosterone production from 20.7 ± 0.38 to 14.2 ± 0.98 ng/mg protein (p<0.01). 
Cortisol synthesis from added deoxycortisol (lpmol/1) was similarly reduced from 
4.7 ± 0.22 to 3.8 ± 0.2 pg/mg protein (p<0.01). Given the high concentrations of 
Ca2+ used in these incubations (350pmol/l), it is perhaps unrealistic to assume that 
changes in [Ca2+]; in intact cells would influence mitochondrial DOC uptake or 
conversion of corticosterone to aldosterone in the same way. Nevertheless the 
hypothesis, that [Ca2+]} inhibits DOC to aldosterone conversion whilst also inhibiting 
signal transduction processes which stimulate steroidogenesis, would explain some 
of the present experiments with R05-4864, diazepam and PK11195. Diazepam and 
R05-4864, in intact cells, could stimulate aldosterone synthesis either through the 
MBR or, by lowering [Ca2*]^  promoting conversion of DOC to aldosterone. PK11195 
would also stimulate steroidogenesis through the MBR but would block R05-4864 
and diazepam effects on DOC conversion. Since PK11195 is only antagonistic at the 
plasma membrane in the presence of an agonist such as diazepam, it would not 
inhibit DOC conversion in the absence of diazepam. A third factor to be borne in 
mind is that at high concentrations, R05-4864 and PK11195 may competitively
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inhibit steroidogenesis by blocking one or more enzyme steps. This might apply 
particularly at concentrations in excess of O.lmM, the range at which 17a- 
hydroxylase and 21 hydroxylase inhibition by midazolam and diazepam becomes 
apparent (see chapter 4).
To clarify which of these three possible processes are involved, it is important in 
future studies to establish clear dose-response relationships, for each of the 
biosynthetic steps involved, to investigate at the same time the effects of these drugs 
on cellular calcium metabolism and lastly to clarify the different pharmacological 
properties of the benzodiazepine receptor ligands tested. It is significant that 
midazolam lowers [Ca2+]j, but may not bind to the MBR yet does bind to central 
receptors. PK11195 stimulates steroidogenesis through the MBR but is an antagonist 
of the plasma membrane receptor. Diazepam and R05-4864 are agonists of the MBR 
and of the peripheral plasma membrane receptor.
In summary, low concentrations of diazepam can increase basal and hormone- 
stimulated aldosterone synthesis in cultured ZG cells. The drug presumably mimics 
the effects of DBI and DBI-like peptides (the proposed endogenous ligands for the 
MBR) and stimulates intra-mitochondrial cholesterol transport. Two high-affinity 
MBR ligands, R05-4864 and PK11195, also increased aldosterone synthesis in 
cholesterol-loaded glomerulosa cells. In addition, diazepam and R05-4864 but not 
PK11195 increased aldosterone synthesised in glomerulosa cells from exogenous 
DOC. Since PK11195 was ineffective, it seems unlikely that the positive effects of 
diazepam and R05-4864 on DOC conversion to aldosterone were MBR-mediated. 
The identification of benzodiazepine receptors in adrenocortical cell membranes and 
the observed effects of benzodiazepines on Ca2+ influx, indicate that the actions of 
R05-4664, diazepam and PK11195 on conversion of DOC to aldosterone may be
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associated with Ca2+-channel function (Fig.5.11).
Fig.5.11
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CHAPTER 6.
GENERAL DISCUSSION.
The present study has considered three inter-related elements of steroidogenic 
control:
(i) The supply of cholesterol.
(ii) The role of Ca2+.
(iii) The activity of biosynthetic enzymes.
These control elements have been studied using several agents which reportedly 
act specifically at particular control sites. I have demonstrated that it is possible for 
some of these agents to affect steroidogenesis by acting at more than one of these 
steroidogenic control elements (see fig 6.1). Investigators should be aware of these 
mixed functions and caution should be exercised when interpreting results of any 
study with the following agents where steroid output is used as an analytical end­
point:
(a) Dantrolene: Dantrolene inhibits Ca2+ release from the sarcoplasmic reticulum 
(129) and has been used to inhibit release of intracellular calcium in bovine zona 
glomerulosa cells (141,142). This property has obvious uses when studying the role 
of intracelluar calcium metabolism in signal-response coupling in A-II-stimulated 
aldosterone synthesis.
I have demonstrated that at concentrations which are required to inhibit A-II- 
mediated release of intracellular calcium, dantrolene also inhibits steroidogenic 
enzymes. The rate-limiting cholesterol side-chain cleavage reaction is particularly 
dantrolene-sensitive. This mitochondrial effect is calcium-independent and probably 
involves direct competitive inhibition between drug and substrate
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(b) High Density Lipoproteins
The main physiological role of HDL is the "reverse transport" of cholesterol from 
peripheral tissues to the liver for catabolism and excretion from the body (100). 
However, HDL has been shown, in vivo and in vitro, to deliver cholesterol to 
steroidogenic cells (100,103). I have demonstrated that HDL subfractions, HDL-2 
and HDL-3, are readily usable sources of substrate for isolated and cultured 
adrenocortical cells. Both subfractions increase basal and A-II-stimulated steroid 
synthesis. However, there is a difference in the responsiveness of freshly isolated 
zona glomerulosa and zona fasiculata/reticularis cells. The aldosterone response to 
HDL is lost at high concentrations of A-II while the cortisol response is not. One 
explanation might lie in the relative dependency of aldosterone and cortisol synthesis 
on Ca2+. Part of the cardioprotective effect of HDL may be due to its inhibitory 
effects on agonist-induced increases in platelet ionised calcium (Simpson and 
Graham, unpublished data; 159,160). My studies, limited as they were, demonstrated 
no significant acute effect of HDL-2 or HDL-3 on either 45Ca uptake or intracellular 
free calcium in zona glomerulosa cells. Under steady state conditions, calcium 
content was lowered by HDL. The added responsiveness of isolated zona 
fasiculata/reticularis cells to HDL probably reflects a greater ability, when compared 
to zona glomerulosa cells, to utilise cholesterol derived from lipoproteins (104).
(c) Benzodiazepines
There are at least two types of benzodiazepine receptor (113,116): central-type 
receptors and peripheral-type receptors.
Central receptors are found throughout the CNS and are associated with the 
GABA-gated chloride ion channel. The therapeutic effects of benzodiazepines as
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tranquillisers and sedatives are mediated via the central receptor
Peripheral receptors have been identified in many tissues outside the CNS but are 
present at highest density in the adrenal cortex where they have been localised to 
the outer mitochondrial membrane (118,119). They are often refered to as 
mitochondrial benzodiazepine receptors (MBR). MBR may play a specialised role 
in steroidogenic control (120). MBR ligands are thought to increase steroidogenesis 
by mimicing the effects of endogenous proteins, called diazepam binding inhibitors 
or endozepines, which have been isolated from steroidogenic tissues (122,123).
I have demonstrated that benzodiazepines, can both stimulate and inhibit 
steroidogenesis. These effects depend on concentration and vary between drugs. For 
example, at high concentrations (>pmol/l), diazepam and midazolam inhibit 
microsomal hydroxylation. In addition, each of these drugs has a prefered site of 
action; diazepam preferentially inhibits 17a-hydroxylase whereas midazolam 
predominantly affects 21-hydroxylase activity. Both of these drugs can also inhibit 
K+-stimulated aldosterone synthesis at lower concentrations (10-20 fold lower) than 
that required to elicit their direct effects on microsomal hydroxylation. Furthermore, 
I demonstrated that benzodiazepines can inhibit depolarisation-induced uptake of 
[Ca2+]0 in zona glomerulosa cells. Similar effects have been reported in other tissues 
(128,177,178). Midazolam also inhibited basal calcium uptake more markedly in 
zona glomerulosa than in zona fasiculata/reticularis cells. Stimulation of aldosterone 
synthesis by K+ is wholly dependent upon the influx of [Ca2+]0 (84). As 
benzodiazepines can block this mechanism, it provides an explanation for the added 
sensitivity of K+-stimulated aldosterone synthesis to these drugs.
At low concentrations (>nmol/l) diazepam increased basal and hormone-stimulated 
(A-II and ACTH) aldosterone synthesis in cultured zona glomerulosa cells. The
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effect on basal synthesis was not just an acute effect and could be induced by pre- 
exposure to the drug. Diazepam’s action on hormone-stimulated synthesis was most 
marked at sub-maximal concentrations of A-II and ACTH, suggesting the 
involvement of a hormone-induced factor which acts at the same site as diazepam 
to affect steroid synthesis. Diazepam has known affinity for the MBR and 
benzodiazepines are proposed to stimulate steroidogenesis by mimicing the effects 
of endogenous ligands for this receptor. The proteins which compete for diazapam 
binding sites have been named diazepam binding inhibitors inhibitors (DBI’s) or 
alternatively endozepines (114,123) and have been identified in the CNS and, at high 
concentrations, in the adrenal cortex (124). These proteins are proposed to increase 
the rate of intra-mitochondrial cholesterol translocation through action at the MBR 
(114). In support of this theory, I have demonstrated that diazepam and R05-4864 
(4-chlorodiazepam) increase aldosterone synthesis in cultured zona glomerulosa cells 
which have been cholesterol-loaded by incubation with HDL subfractions. Both 
diazepam and R05-4864 can also increase DOC-stimulated late pathway activity. If 
the MBR influences one type of mitochondrial transport mechanism, cholesterol 
translocation, then it is interesting to speculate that it may also facilitate transport 
of another steroid precursor which requires acccess to the inner mitochondrial 
membrane; DOC. The adrenal MBR has also been reported as having a direct role 
in the transport of porphyrins, which are necessary for the function of steroid 
hydroxylase enzymes (121). Thus it is possible that the MBR may form part of a 
multi-faceted regulatory mechanism that controls not only transport of steroid 
intermediates but may also affect uptake of other components essential for 
steroidogenesis.
PK11195 is not a benzodiazepine but is an isoquinoline carboxamide. This
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compound can also increase aldosterone synthesis stimulated by both HDL-2 and 
HDL-3. PK11195 has high affinity for the MBR and so presumably exerts its effects 
on steroid synthesis by increasing intra-mitochondrial cholesterol transport in a 
manner similar to benzodiazepines. However, the drug has no effect on conversion 
of DOC to aldosterone. This makes it less likely that the stimulatory effects of 
diazepam and R05-4864 on late pathway activity are mediated through the MBR. 
They probably involve interaction with cell membrane benzodiazepine receptors 
which are associated with Ca2+-channel function.
In summary, my studies with benzodiazepines have demonstrated that they can 
influence aldosterone synthesis through three different mechanisms.
(i) ^nmol/1: Aldosterone synthesis is stimulated, probably via the MBR, by 
increasing the rate of cholesterol transport from the outer to the inner mitochondrial 
membrane.
(ii) >nmol/l: Potassium-stimulated aldosterone synthesis is inhibited by a reduction 
in uptake of [Ca2+]0. Whether this is mediated via central or peripheral receptors 
remains to be ascertained. Interestingly, others have recently reported that peripheral 
benzodiazepines can inhibit both K+ and A-II-stimulated aldosterone synthesis in 
isolated bovine glomerulosa cells by inhibiting influx of [Ca2+]0 into the cell (191).
(iii) >pmol/l: Aldosterone and cortisol synthesis are inhibited. The results indicate 
that midazolam and diazepam are competitive inhibitors of microsomal hydroxylases 
in steroidogenic tissue.
Thus the net effect of benzodiazepines on aldosterone synthesis will depend upon 
the relative effect of the drug on each of these mechanisms. This in turn depends 
upon the identity of the individual drug and on its concentration.
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